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Abstract 
 
A CORRELATIONAL ANALYSIS OF SECONDARY DATA FOR FACTORS 
INFLUENCING GRADUATION FROM ADULT DRUG COURT 
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Philosophy at Virginia Commonwealth University 
 
 
Virginia Commonwealth University, 2016 
 
Major Director: Patrick V. Dattalo, Ph.D. 
Professor 
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The proliferation of drug courts throughout the world over the last two decades presents 
an opportunity and a challenge.  The drug court approach involves a combination of treatment 
and judicial supervision which is a diversion from incarceration and/or ‘traditional’ criminal 
justice supervision.  Despite widespread study of drug courts, there is much that researchers still 
do not know and there is still controversy as to how and why drug courts work.  This research 
study is an examination of secondary data from an urban, mid-Atlantic drug court to attempt to 
correlate factors that contribute to success (as defined by graduation) in drug court.  This study 
examines drug courts using Life Course Theory, Social Capital Theory and Recovery Capital 
Theory as a theoretical foundation for understanding the influences of drug courts on 
participants.  Findings from the Discriminant Function Analysis employed in this study 
demonstrate low to moderate ability to predict drug court graduation and program attrition based 
on a combination of demographic information and drug court program requirements.  Among the 
factors found to contribute to drug court success were participants having children, their 
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employment status, 30-day abstinence, age, and race.  Additional implications for social workers 
practicing in drug courts are discussed as well as suggestions for future research directions in the 
study of drug courts.
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Chapter 1: Introduction 
We have an incarceration rate in the United States - the world's greatest democracy 
- that is five times as high as the incarceration rate of the rest of the world.  There's 
only two possibilities here ... Either we have the most evil people on earth living in the 
United States or we are doing something dramatically wrong in terms of how we 
approach the issue of criminal justice.  Former US Senator Jim Webb (Webb, 2009) 
 
Since their inception in the late 1980’s, drug courts have become a fixture of criminal 
justice throughout the United States. There are currently 2,968 Drug Courts in operation in every 
US state and territory (“How Many Drug Courts”, 2016). The first drug court was established in 
Dade County, Florida in 1989 (Belenko, 1999). The original drug courts were an effort to deal 
with a “revolving door” justice system where the same offenders cycled in and out of courts and 
prison (Huddleston, Freeman-Wilson, Marlowe, & Roussell, 2005).  The courts offered a way to 
deal with the root cause of low-level drug offenses by addressing addiction, seen as the primary 
problem of these offenders.   
The genesis of drug courts was just the latest attempt to find a balance between punitive 
measures and recognition of drug abuse as a social and physical problem in need of treatment as 
well as punishment.  The first major national narcotics law, the Harrison Act of 1914, was 
intended to curb recreational drug use and nonmedical addiction (Musto, 1973).  Since that time, 
there have been numerous initiatives aimed at coming to terms with drug use in American 
society.  These attempts have ranged from “tough on crime” efforts such as the “Three Strikes 
and You’re Out” initiative in California during the nineties to a current major initiative of some 
states legalizing marijuana.  Drug courts emerged during the worst years of the 1980’s crack 
epidemic and, despite the emergence of new challenges remain as relevant today as they were 
thirty years ago. 
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There is a historical context for the emergence of drug courts as a specialized justice 
system intended to address a particular population of concern and a set of social problems.  In 
1899, the Chicago Juvenile Court was concentrated on “petty offenses and salvageable offender” 
(Fox, 1970).  Prior to this time, juveniles were tried and judged in the adult justice system (the 
only one that existed up to that point).  It can be argued that drug courts have grown from those 
earliest efforts at courts acting not only as a means of punishment but also as a means of 
addressing a particular population.  It can further be argued that, over time, these courts are an 
effort to address a social problem and the root causes of crime.  While not unprecedented in the 
effort to ‘reform’, drug courts are a unique innovation very much designed to address a modern 
social problem. 
This chapter will lay the groundwork for this study by providing a definition of drug 
courts and their basic tenets.  The remainder of the chapter will provide a problem statement 
outlining the current context and environment in which drug courts operate, discuss the 
significance of drug courts in the field of social work and describe a brief study overview. 
Defining Drug Courts 
Drug courts were born of necessity after the growth of drug related arrests threatened to 
overwhelm the criminal-justice system in the early 1980’s (Belenko, 1999).   The emergence of 
crack cocaine was a particularly onerous problem driving the increase in drug related arrests and 
incarcerations.  The result of this huge increase in drug crime and arrests was a “revolving door” 
system with drug offenders cycling in and out of the system with no apparent progress being 
made.  Faced with the lack of resources brought about by the crack epidemic, many jurisdictions 
began to seek alternatives to the traditional court approach to drug offenses and addiction.  The 
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innovative approach these new courts brought to bear was the effort to quickly identify substance 
abusing offenders and place them under strict court monitoring and community supervision 
(Huddleston, et al., 2005).  These courts represented an innovative paradigm shift at the time, 
best described as “therapeutic jurisprudence.”  To quote the Department of Justice: 
The premises of therapeutic justice are that law is a therapeutic agent; positive 
therapeutic outcomes are important judicial goals; and the design and operation of the 
courts can influence therapeutic outcomes. (Simpson, 2015). 
 
The quotation above represents the sentiment that treatment professionals and law enforcement 
officials share the same goal when it comes to persons with substance use disorders—a reduction 
in substance abuse and in criminal behavior related to that substance abuse. 
 Drug courts represent a coordinated effort that brings together the efforts of judiciary, 
prosecution, defense bar, probation, law enforcement, treatment, mental health, social services 
and child protective services (Huddleston, et al., 2005) to break the cycle of drug addiction, 
criminal behavior and substance abuse.  This coordinated approach brings together multiple 
resources, from multiple agencies, in a way not possible prior to the establishment of drug courts.  
In this blending of systems, the drug court participant undergoes an intensive regimen of 
substance abuse and mental health treatment, case management, drug testing, and probation 
supervision while reporting to regularly scheduled status hearings before a judge (Huddleston, et 
al., 2005).  Job skills training, family or group counseling, and other life-training skills are 
examples of the innovative services a drug court may provide participants (Huddleston, et al., 
2005).  This comprehensive approach is a significant change from the “lock them up and throw 
away the key” mindset of many mainstream courts.  By addressing the problem through a less 
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paternalistic lens and more cognizant of the application of power, drug courts represent a unique, 
new and proactive way to deal with low level drug offenders. 
According to John Walters, Director of the Office of National Drug Control Policy, “drug 
courts are one of the most significant criminal-justice initiatives in the past twenty years” 
(Huddleston, et al., 2005).  The rapid growth of drug courts supports this sentiment.  Drug courts 
have proliferated throughout the country at a rapid pace since the establishment of the first one in 
1989.  Currently, 50 states plus the District of Columbia, Northern Mariana Islands, Puerto Rico, 
Guam, two Federal Districts and 121 tribal programs have drug courts that are in operation or are 
being planned (“Drug Courts”, 2015).   
 
Statement of the Problem 
Addiction and rising incarceration rates are problems that continue to vex American 
society and the American justice system.  These twin problems directly influence the need for a 
policy solution like drug courts. 
The American prisoner population has skyrocketed over the last several decades.  The 
chart below represents some of the latest imprisonment statistics from the Bureau of Justice 
Assistance (BJA).  According to the BJA, since 1978 the number of federal and state prisoners in 
the US has gone from below 200,000 to just over 1.5 million (See Figure 1.1).  While the last 
several years has seen an encouraging downturn in the prisoner population, this represents a 
staggering increase in the last several decades.  Taking into account jail populations, about 1 in 
every 108 adults was incarcerated in prison or jail at year end 2012 (Bureau of Justice Statistics, 
2012). Even though other countries have also grown their prison populations over some of this 
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period, the United States stands out as an “overachiever” in this area.  The Unites States has 5% 
of the world’s population, yet the United States accounts for 25% of the world’s prison 
population (Nagin, 2014). 
Figure 1.1- The Growth of the US Prison Population 
 
 
The reasons for the increase in the US prison population have been well documented.  
Stricter sentencing policies, particularly for drug-related offenses, rather than rising crime, are 
the main culprit behind skyrocketing incarceration rates (Schmitt, Warner, & Gupta, 2010). 
Indeed, crime was on the rise during the period of the late eighties and early nineties when drug 
courts first began to spring up.  However, since that time, even as the total number of violent and 
property crimes fell, the incarcerated population continued to expand rapidly (Schmitt et al., 
2010).  There is also a social justice component of imprisonment in the US that cannot be 
ignored.  African-Americans are the most imprisoned group in the US.  While African-
Americans comprise only 12% of the US population, this group comprises nearly 40% of the 
nation’s inmates, with some researchers estimating that more than one in four African-American 
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men will spend time behind bars (Hetey & Eberhardt, 2014). Arrests for drug offenses remain 
highly concentrated in urban African-American and Hispanic communities beset with high 
poverty rates and other forms of concentrated disadvantage (Sevigny, Pollack, & Reuter, 2013). 
This inordinate sentencing that makes the racial breakdown of US prisoners an inverse 
representation of the general population is yet another reason why drug courts in urban, majority 
African-American areas like Richmond such an important area of study. 
Drug offenses are also a major reason for the increase in the prison population.  Figure 
1.2 below illustrates the huge increase of people in prisons and jails for drug offenses between 
1980 and 2014.  The “war on drugs” has drastically increased incarceration rates since the 1980s, 
as a growing number of drug-using offenders have been sent to prison and jail for ever increasing 
length of sentences (Sevigny et al., 2013).  While we have seen recent trends to reverse the rigid 
and increasingly punitive sentences wrought by the drug war, much of the damage is done.  Even 
as measures like drug courts seek to impact the prison population, there is a generational problem 
that may take decades to resolve. 
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Figure 1.2- Number of People Imprisoned for Drug Offenses 
 
Troubling trends in drug abuse and substance use disorders further highlight the 
intractable problems drug courts are attempting to address.  According to the Centers for Disease 
Control and Prevention (CDC), 105 people in the United States die every day from drug 
overdoses (CDC.gov, 2016).  Further, according to the National Institute on Drug Abuse 
(NIDA), 38,329 Americans died from drug overdoses in 2010.  That number is higher than the 
31,672 killed that same year in the US by guns and higher than the 33,687 that died in US car 
accidents (“Drug Overdoses Kill”, 2015).  These numbers seem to draw far less concern than 
recent public concern over gun violence and terrorism which kill fewer Americans.   
It should be noted that there are huge numbers of Americans in need of substance use 
disorder treatment who are not receiving services or are receiving inadequate services.  Figure 
1.3 is a chart from the 2014 Substance Abuse and Mental Health Services Administration 
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(SAMHSA) national survey outlining the unmet need for substance abuse treatment in the US. 
The chart below illustrates that, of those who needed substance use disorder treatment, only 
8.9% received treatment in 2014—up from the previous year.  Across all racial and ethnic 
groups, a recent National Institute of Health (NIH) study found high rates of unmet need for 
substance use treatment, with most estimates over 90% across all need definitions, regardless of 
racial/ethnic category (Mulvaney-Day, DeAngelo, Chen, Cook, & Alegría, 2012).  It is clear that the 
gap between those who need treatment and those who get it is huge, illustrating further need to 
think creatively in how and where substance use disorder treatment is delivered.  
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Figure 1.3- Unmet Substance Abuse Treatment Needs
 Another national factor influencing the huge influx into prisons during the war on drugs 
is discrepancy in sentencing for different forms of cocaine.  The Anti-Drug Abuse Act of 1986 
created harsher penalties for possession of crack cocaine than for the powdered form of cocaine 
which resulted in a 100 to 1 sentencing disparity (Hessick & Andrew, 2010). Although the Fair 
Sentencing Act of 2010 went a long way towards eliminating this disparity (Graham, 2011), 
much of the damage had been done.  Since the two forms of cocaine are pharmacologically 
indistinguishable, by dictating harsher sentences for possession of crack than for possession of 
powder, the law is more severely punishing the poor, who obtain the affordable form of cocaine 
(crack), than the affluent, who obtain the more expensive form of the same drug (powder) 
(Coyle, 2002).  The implications of this policy on who goes to prison for cocaine use represent a 
social justice issue that drug courts putatively help address. 
With regard to the local area, according to the State Attorney General’s Office, heroin 
overdose fatalities in Virginia have more than doubled from 100 deaths in 2011 to 239 deaths in 
2014 (oag.state.va.us, 2015). The fatalities increase when examining just the last year of that 
time period in which the number of fatal heroin overdoses in Virginia increased by 57.8% in 
2013 compared to 2012, and represented 23.4% of all drug/poison deaths (Virginia Chief 
Medical Examiner’s Office, 2014). The central region of Virginia (in which Richmond City is 
located), had the highest number of fatal heroin overdoses in the state in 2013 (78, 36.6%) with 
Richmond City having one of the highest rates of deaths from heroin overdose (21, rate of 9.8%). 
There is a direct link between illicit drugs and crime.  Over 80% of adult offenders in the 
US misuse drugs or alcohol, meaning they were arrested for a drug- or alcohol-related offense, 
were intoxicated at the time of their offense, reported committing their offense to support a drug 
or alcohol problem or they have a significant history of substance abuse or substance abuse 
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treatment (Marlowe, 2015).  Geographically, Interstate 95 transverses the city and is known as 
the drug transportation corridor for the east coast. As illegal substances are being routed through 
this region, the opportunity and likelihood for illicit drugs to be distributed or sold in this 
community is increased. The metro Richmond area has been designated a HIDTA (High 
Intensity Drug Trafficking Area) along with the Washington, DC and Baltimore regions since 
2005 (“HIDTA Counties by State”, 2015). This designation is to some degree confirmed by the 
disproportionate number of drug/narcotics arrests in Richmond as compared to rest of the state. 
For persons 18 and over, the number of arrests for drug/narcotic offenses in Richmond (2,044) 
represents 5.6% of the state total (30,464).  
The human scope of these problems should be troubling enough, but there is also a 
substantial financial cost to incarceration and drug abuse.  A recent study by the VERA Institute 
for Justice estimated that the total cost of imprisonment in just the 40 states participating in their 
survey was over $38 billion (Henrichson & Delaney, 2012).  Even setting aside the human toll of 
incarceration, a small decrease in the number of individuals incarcerated would achieve 
significant financial savings for taxpayers.  When one includes the cost of illicit drug abuse to 
the US, the numbers become truly staggering.  According to the National Institute of Health 
(“Trends and Statistics”, 2015), the overall costs to American society of illicit drug abuse is $193 
billion.  Taken together, the incarceration costs and societal costs approach $231 billion.  This 
amount is more than one third of the $668 billion (Walker, 2013) that the US spent on defense in 
2012 (note that this is defense spending in a year that the US was conducting 2 active wars 
overseas).   
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Purpose of This Study 
The objective of this study is to identify particular aspects of the drug court intervention 
and social/demographic aspects of drug court participants that contribute to success in 
completing a drug court program.  The secondary data set contains a wealth of information on 
the participants in one particular program, captured at various time points, which provides a rich 
picture of the participants in the program.  The aim was to find particular aspects of the program 
and participants that are statistically associated with graduation (successful completion) from the 
drug court program.  The intended outcome of this study is a statistical understanding of what 
variables, selected for study based on theoretical guidance and the literature, have the highest 
impact on graduation rates from drug court. 
This study attempts to further the knowledge base of drug courts by isolating the most 
effective elements of one particular drug court program.  As drug courts proliferate throughout 
the nation and participation in those courts increases, there is a need for and value in actionable 
research.  By demonstrating what works in drug courts and what potential risk factors are for 
certain groups, drug court professionals can increase chances for success for all participants and 
screen participants accordingly.  Further knowledge of what contributes to drug court success 
will also allow policy makers and clinicians to adjust programs for maximum success of 
participants and allow for increased impact of an important criminal justice innovation. 
Chapter 2 discusses more fully the theoretical grounding of this study.  This study uses 
Life Course Theory, Social Capital Theory and Recovery Capital Theory to account for inherent 
demographic traits of participants and societal/judicial influence on drug court participants. This 
study attempts to arrive at a conclusion that will merge the ‘macro’ and ‘micro’ in a way 
consistent with the approach of social work and informative of the impacts of drug courts. 
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Implications for Social Work 
The preceding data outlining prison statistics, drug use problems and the exploding costs 
of these challenges make research of drug courts a natural fit for social workers and social work 
scholarship.  While drug courts have been widely addressed in criminal justice and substance use 
disorder literature, the topic has been very sparsely addressed in social work literature.  Tyuse 
and Linhorst (2005) outline the ways in which social workers may interact with these courts:  
[social workers] may be members of a task force that develops a specialized court, or 
they may fill administrative or direct services positions in substance abuse, mental health, 
or criminal justice agencies that are parts of the court system and network of service 
providers. Social workers also may have sporadic contact with drug courts and mental 
health courts, such as when a client or a client's family member encounters the criminal 
justice system and has a substance abuse disorder or mental illness. (p. 238). 
Tyuse and Linhorst further point out that regardless of what interactions social workers may have 
with drug courts, that a working knowledge of the legal system and available local substance use 
disorder treatment resources will aid them in serving their clients and improve their efficacy in 
their profession. 
 Social workers must also be cognizant of the more general issues of the ever increasing 
incarcerated population and the fact that it is reflective of vulnerable minority populations, 
further marginalized by the presence of substance abuse issues.  Social workers educated in 
criminal justice matters in general and drug courts in particular are able to better advocate and 
pursue social justice on behalf of clients affected by what has become an overwhelming societal 
issue. 
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This vital and evolving area of study is just beginning to impact our society. There is a 
great contribution to be made in going beyond the efficacy question and attempting to understand 
the components of an intervention that was born of “muddling through” an intractable problem.  
Indeed, by understanding why a drug court works, we can further hone what has already proven 
to be an effective, holistic and more humane way of dealing with an enormous and complex 
social problem.  
Study Overview 
Chapter two of this study begins with a review of the relevant literature on drug courts.  
The literature review explores the current guiding principles of drug courts, the current 
understanding of the effectiveness of drug courts, how drug courts have been performing from a 
cost standpoint, current participation in drug courts and details of the drug court that is the focus 
of this study.  Chapter two closes with a review of the concept of Therapeutic Jurisprudence and 
the theoretical foundation for this study—Life Course Theory, Social Capital Theory and 
Recovery Capital Theory.   
Chapter three begins with an overview of human subjects’ protection observed in this 
study then moves on to a description of the instrument used to collect data, a brief discussion of 
secondary data analysis, validity issues related to the data collection instrument, a description of 
the independent and dependent variables and closes with the data analysis plan.  Chapter four 
presents the results of the study, and Chapter five contains a discussion of the results, limitations 
discussion and implications for future research. 
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Chapter 2: Literature Review and Theoretical Grounding 
Drug courts have been studied extensively since their inception in the late nineteen-
eighties.  While the literature is extensive, the vast majority of study has been done in criminal 
justice with precious little study in the social work field.  The scarce social work study on this 
subject was covered in chapter one.  The following literature review outlines the current state of 
the understanding of drug courts and what elements of drug courts are currently considered to be 
potential factors for success.  This review also includes an overview of the key elements of drug 
courts and some of the current, universally accepted tenets of drug courts.  An overview of the 
Richmond Adult Drug Court also ties the court in which this study occurred to the larger drug 
court movement. 
Following the literature review is an overview of the theoretical basis for this study, Life 
Course Theory, Social Capital Theory, Recovery Capital Theory and a conceptual model 
outlining how those theories are applied in this study.  Theory, as simply defined by Frankfort-
Nachmias & Leon-Guerrero (2010), is an elaborate explanation of the relationship between two 
or more observable attributes of individuals or groups.  Using life course theory, this chapter 
establishes a theoretical model to serve as the basis of this study.  The theoretical model 
establishes a paradigm, or basic set of beliefs that guides action (Guba, 1990).  The theoretical 
model outlined in this chapter attempts to understand the myriad micro and macro influences on 
drug court participants and both demographic and justice system factors influencing success.  By 
attempting to find influencing factors, understood through the prism of life course theory, this 
study will attempt to find links between those influences and success in drug court programs. 
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Drug Court Basic Components and Evidence of Efficacy 
The foundation of almost any drug court program in the US is the 10 Key Components of Drug 
Courts, as defined by the National Association of Drug Court Professionals (NADCP): 
Figure 2.1 10 Key Components of Drug Courts 
1. Drug courts integrate alcohol and other drug treatment services with justice system case 
processing. 
2. Using a nonadversarial approach, prosecution and defense counsel promote public safety 
while protecting participants’ due process rights. 
3. Eligible participants are identified early and promptly placed in the drug court program. 
4. Drug courts provide access to a continuum of alcohol, drug, and other related treatment 
and rehabilitation services. 
5. Abstinence is monitored by frequent alcohol and other drug testing. 
6. A coordinated strategy governs drug court responses to participants’ compliance. 
7. Ongoing judicial interaction with each drug court participant is essential.  
8. Monitoring and evaluation measure the achievement of program goals and gauge 
effectiveness. 
9. Continuing interdisciplinary education promotes effective drug court planning, 
implementation, and operations. 
10. Forging partnerships among drug courts, public agencies, and community-based 
organizations generates local support and enhances drug court program effectiveness. 
(“13 Key Principles, 2015) 
More recently, the International Association of Drug Treatment Courts (IADTC) adopted the 10 
Key Components but added three components focusing on the social reintegration of 
participants, ensuring flexible treatment for indigenous populations and ethnic minorities, and 
planning for aftercare recovery services (Marlowe, 2015): 
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Figure 2.2: Additional 3 Drug Court Components 
1. Ongoing case management includes the social support necessary to achieve social 
reintegration. 
2. There is appropriate flexibility in adjusting program content, including 
incentives and sanctions, to better achieve program results with particular 
groups, such as women, indigenous people and minority ethnic groups. 
3. Post treatment and after-care services should be established in order to enhance 
long term program effects. 
(“13 Key Principles, 2015) 
While it should be noted that most US drug courts still adhere to the 10 Key components 
outlined above, that in practice, if not in stated purpose, the three additional components are 
observed in many US drug courts including the Richmond Adult Drug Court where data for this 
study was collected. 
These components combine to form individualized interventions that simultaneously 
provide drug treatment to drug abusing offenders and hold them accountable for their behavior 
(Mitchell, Wilson, Eggers, & MacKenzie, 2012).  It is important to understand that drug courts 
emerged without a solid theoretical basis and it would be fair to say that drug court policy was 
developed using the classic policy development description from Lindblom (1959) of “muddling 
through.”  It is interesting, albeit common in the criminal justice system, that drug courts’ initial 
expansion occurred without a solid body of empirical evidence establishing their effectiveness in 
reducing criminal behavior (Mitchell et al., 2012). 
One can find a range of opinions on drug courts from definite contentions that “drug 
courts work” (Meyer & Ritter, 2001) to contentions that there is a “lack of evidence supporting 
the effectiveness of drug courts” (Anderson, 2001). This author contends that drug courts should 
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be considered yet another intervention, albeit with the force of the judicial system behind it.  In a 
summary of existing drug court research the General Accounting Office (GAO) states: 
Some studies showed positive effects of the drug court programs during the period 
offenders participated in them, while others showed no effects, or effects that were 
mixed, and difficult to interpret.  Similarly, some studies showed positive effects for 
offenders after completing the programs, while others showed no effects, or small and 
insignificant effects. (Wilson, et al., 2006) 
It seems with any intervention, the more extensive the literature on that intervention, “the greater 
the likelihood that it will contain conflicting findings that can lead researchers to different 
conclusions” (Marlowe, 2004). 
 However, the vast majority of literature reviewed by this author points to the efficacy of 
drug courts and the superior outcomes in drug courts as compared with traditional, punitive court 
models.  Some authors, particularly (Whiteacre, 2004) make valid points regarding a great deal 
of the drug literature with criticism that there are fatally flawed sampling methods.  However, 
randomized experimental designs conducted in the Maricopa County (Ariz.) Drug Court (Turner 
et al., 1999), the Baltimore City Drug Treatment Court (D. C. Gottfredson, Najaka, & Kearley, 
2002)(D. C. Gottfredson & Exum, 2002), and the Las Cruces (New Mexico) DWI Court 
(Breckenridge et al., 2000) all point to the success of drug courts.  Although drug courts enjoy 
empirical support, the fact remains that some drug courts “work” better than others (Shaffer, 
2011). One goal of this study is to understand what elements contribute to drug court success in 
an attempt to expand the knowledge base of what does “work,” and how success can be 
replicated. 
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One of the glaring issues facing drug court research is that of generalizability.  It could be 
argued that it is almost impossible to get a scientifically accurate picture of how effective drug 
courts are due to variations in how they operate nationwide.  Differences exist on who is eligible, 
how they are selected, what treatments are available and, very importantly, how court practices 
affect the outcome (Harrell, 2006).  Longshore, et al. (2001) does attempt to provide a five-
dimension framework for operationalizing drug court practices.  Longshore, et al., attempt to 
define the five key dimensions of drug courts by creating a scale to measure: 
1. The Degree of Leverage.  This dimension is a measure of how much leverage  
(i.e.: possibility of serious punishment for non-participation or for failure to  
complete the program. 
2. Population Severity.  This is a measure of the severity of the population both with  
level of addiction and criminal background. 
3. Program Intensity.  This is a way to gauge how intense treatment and other  
services (such as employment assistance or housing assistance) are in a particular 
program. 
4. Predictability.  This scale asks how predictable and/or consistent sanctions and  
rewards are in any drug court program. 
5. Rehabilitation Emphasis.  This measure asks how much the punitive versus 
rehabilitative aspects of the program are emphasized.   
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While the framework developed by Longshore et al. does provide for some useful tools to 
compare different programs, it can still be argued that drug courts could benefit by finding a way 
to implement evidence-based standardized practices nationwide.  Thus, making it easier to 
aggregate and interpret many wildly different drug court statistics and making a case that the 
public and lawmakers could easily understand.  This author would argue that another vitally 
important factor contributing to the generalizability of drug court research (which Longshore et 
al. do not address) is the varying array of treatments available.  Different areas have differing 
resources and treatment providers.  While this study, by design and necessity, focuses on one 
drug court out of thousands worldwide, the aim is —with the aid of theoretical approaches 
discussed later in this chapter—to arrive at concretely generalizable factors that help drug courts 
succeed. 
Cost Effectiveness of Drug Courts 
 Most observers would agree that drug courts are a more humane and proactive way to 
deal with lower level drug offenders in the criminal justice system.  However, an added benefit is 
their long term cost effectiveness.  A study by Carey et al., (2008) found drug courts achieved a 
significantly lower per-person taxpayer investment than traditional criminal justice measures.  
Another study by Lowenkamp, Holsinger, & Latessa (2005) found a total of $2,328.89 is saved 
per participant in outcome costs. That study further found that, if victimization costs (property 
damage, etc.) are included, that number rises to $3,596.92 per offender.  Taking off the table 
differing ideologies with regard to how best to deal with drug crime, those numbers are 
compelling from any standpoint. 
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A study by Bhati, Roman, & Chalfin (2008) found that of the almost 1.5 million arrestees 
at risk of drug abuse or dependence, 109,921 (about 7%) met drug court eligibility requirements. 
Of the 109,921 eligible, approximately half (55,364) were actually enrolled in a drug court 
program. In aggregate, just 3.8% of the at-risk arrestee population was treated in drug court.  
Drug courts as an intervention have a large and growing body of literature pointing to their cost 
effectiveness and success in preventing recidivism.  The numbers of individuals participating in 
these programs can and should grow.  Studies like this one helping to further isolate the effective 
components of drug courts, and isolating which people are more likely to succeed, will help to 
further institutionalize and grow drug courts. 
The Richmond Adult Drug Court 
The variation in drug courts throughout the nation necessitates some familiarity with the 
drug court that is the subject of this study.  Appendix 1 to this study is the handbook for the 
Richmond Adult Drug Treatment Court (RADTC).  The drug court model emphasizes formal 
contractual agreements between the participants, mental health service organizations, and the 
court system. In this treatment modality, the judge, prosecuting attorney, defense counsel, and 
participant agree that the participant will complete a program that is approximately one year long 
and contains three, 4-month “phases” (Stein, Deberard, & Homan, 2013).  The RADTC program 
incorporates the phases model via a five phase, highly structured, outpatient treatment program 
that lasts a minimum of 16 months. The length of the phases varies depending upon individual 
progress.  The five phases of the RADTC as outlined in their manual are 
Evaluation/Probationary Period (approximately 30 days), Phases 1 through III each lasting 
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approximately 17 weeks and an aftercare component (approximately 6 months for the period 
post-graduation).   
The phases of the RADTC are a reflection of the general course of most drug court 
programs.  The early phases of RADTC drug court reinforce the importance of abstinence and 
social connection by requiring the following:  
 Secure employment or enrollment in school. Failure to obtain employment, or remain 
employed or enrolled in school, will result in daily reporting for group sessions and/or 
community service; 
 Attend the required number of recovery group meetings per week [e.g., twelve step 
AA/NA]; 
 Secure a home group and a sponsor; 
 Oral and/or written presentation of an acceptable first step; 
 Attendance at a minimum of fifty-one (51) group sessions with satisfactory group 
participation; 
 Meet weekly with designated staff as directed; 
 Attendance at all scheduled groups and individual sessions, recovery group meetings and 
drug screens (no missed sessions for thirty (30) days prior to phase movement); 
 Submit to drug screens as directed by staff; 
 Participate in recreation and fellowship activities; 
 Appear in court as required; 
 Completion of 15 hours of community service; 
 Make timely payments of Drug Court fee 
(Participant Manual, 2016) 
 
The RADTC phases are explained in full in Appendix 1 and summarized briefly in Table 2.1 
below. The phases are progressively less restrictive as time passes with drug testing decreasing 
in frequency and fewer face to face interactions required of participants.   
 
 
 
 23 
Table 2.1 
Drug Court Phases  
Phase Duration 
Evaluation/Probationary Period 30 Days 
Phase I Approximately 17 Weeks 
Phase 2 Approximately 17 Weeks 
Phase 3 Approximately 17 Weeks 
Aftercare Approximately 6 Months 
 
There is also a graduated sanction grid that is in keeping with the key components of drug courts 
and generally accepted drug court principals.  The following 2 pages contain the sanctioning 
grids for the RADTC. 
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Table 2.2 
RADTC Sanction Grid 
   
ACTION 
 
1ST INCIDENT 
 
2ND INCIDENT 
 
3RD INCIDENT 
 
4TH + INCI`DENT 
MISSED 12 STEP 
/ RECOVERY 
MEETINGS 
8 hours of 
community service. 
Meetings must be 
current by the next 
week 
16 hours of 
community service 
No credit for group 
until meetings are 
current 
2 days in jail 
 
No credit for 
group until 
meetings are 
current 
5 days in jail + restart 
current phase 
Meet with treatment 
team 
FORGED/ 
ALTERED DRUG 
COURT 
DOCUMENTS 
3 days in jail for 
each forged 
document 
Revocation from 
the program and 
CA will 
recommend active 
incarceration 
  
 
DRUG/ 
ALCOHOL 
TESTING AND 
TAMPERING 
   
 Late, Missed 
Screens, Unable to 
give, Adulterated, 
Diluted screens  
 
Each participant is 
responsible for 
submitting a 
sample that is able 
to be tested.  Dilute 
screens will be 
considered positive. 
 
5 days in Jail 
5 additional days in 
jail will be received 
if the participant 
tests positive for 
the entire week 
Possible referral 
for 
Detox/Inpatient/ or 
STEP UP & OUT 
 
 
10 Days in Jail 
5 additional days in 
jail will be received 
if the participant 
tests positive for 
the entire week 
Possible referral for 
Detox/Inpatient/ or 
STEP UP & OUT 
 
 
20 days in Jail 
5 additional days 
in jail will be 
received if the 
participant tests 
positive for the 
entire week 
Possible referral 
for 
Detox/Inpatient/ 
or STEP UP & 
OUT 
 
 
30 days in jail 
Possible referral for 
Detox/Inpatient/ or 
STEP UP & OUT 
 
 
5th INCIDENT 
Minimum of 
45 days, STEP UP & 
OUT, 
or 
Revocation from the 
program.  CA will 
recommend active 
incarceration. 
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Table 2.2 Cont. 
RADTC Sanction Grid 
   
 
ACTION 
 
1ST INCIDENT 
 
2ND INCIDENT 
 
3RD INCIDENT 
 
4TH + INCIDENT 
 
MISSED 
GROUP & 
INDIVIDUAL 
TREATMENT 
SESSION 
Excused missed 
sessions will be 
made up 
 
8 hrs.  In- House 
Community Service 
 
Missed session will 
be made up within a 
week 
 
3 days in jail 
+written or oral 
presentation 
 
Missed sessions 
will be made up 
within a week 
 
5 days in jail 
 
Missed sessions 
will be made up 
within a week. 
 
 
Revocation from the 
program.  CA will 
recommend active 
incarceration 
 
MISSING JOB 
SEARCH FORMS 
 
Verbal reprimand 
 
Job deadline 
 
2 days in jail 
 
5 days in jail 
FAILURE TO 
SUBMIT THE 
REQUIRED 
HOURS FOR 
EMPLOYMENT, 
EDUCATION, 
AND/OR 
COMMUNITY 
SERVICE 
 
3 days in jail 
 
6 days in jail 
 
Meet with 
treatment/ 
probation team 
 
9 days in jail 
 
Meet with 
treatment/ 
probation team 
 
Revocation from the 
program.  CA will 
recommend active 
incarceration 
 
CURFEW 
VIOLATION 
 
Indefinite 8p 
Curfew 
**2 days in jail if 
out the entire night 
 
3 days in jail + 
Indefinite 8p 
Curfew 
 
5 days in jail + 
Indefinite 8p 
Curfew 
 
Revocation from the 
program.  CA will 
recommend active 
incarceration 
PROVIDING 
FALSE 
INFORMATION 
TO STAFF 
ABOUT 
MATERIAL 
FACTS 
e. g., residence, 
employment 
 
3 days in jail  
 
5 days in jail  
 
10 days in jail 
 
Revocation from the 
program.  CA will 
recommend active 
incarceration 
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LATE TO 
COURT 
SANCTIONED AT THE DISCRETION OF THE JUDGE 
 
An examination of the phases and sanctioning grids of the RADTC shows that not only 
are most of the key components of drug court present in the RADTC but also key components of 
social connection and social control.  A major focus of RADTC interventions is to build social 
bonds with judges, treatment providers, aftercare sponsors, and other former drug users who 
have decided to participate in this voluntary intervention. The RADTC also attempts to locate 
employment and encourage stable home lives for their participants. Offenders who participate in 
these programs are clearly presented with an opportunity for major life turning points (Sampson 
& Laub, 2005).  This notion of connection to society and social control leads to the theoretical 
grounding for this study. 
Therapeutic Jurisprudence 
As a concept, therapeutic jurisprudence is still relatively new.  Professor David Wexler 
first used the term in 1987 in a paper delivered to the National Institute of Mental Health (Hora, 
Schma, & Rosenthal, 1998).  Nailing down an exact definition of Therapeutic Jurisprudence is 
not as straightforward a task as it would seem at first.  A solid working definition is given by 
(Winick & Wexler, 2001) who describe it as an interdisciplinary approach to legal scholarship 
that has a law reform agenda. Therapeutic jurisprudence seeks to assess the therapeutic and anti-
therapeutic consequences of law and how it is applied.  When they were first created, the 
founders of drug treatment courts gave little thought to a theoretical or jurisprudential basis for 
them (Fulton, Hora, 2002).  Therapeutic Jurisprudence has emerged in public policy not as a 
theory but more as a framework for approaching a common goal of a more comprehensive, 
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humane, and psychologically optimal way of handling legal matters (Daicoff, 2000).  From the 
movement of Therapeutic Jurisprudence, numerous problem solving courts have emerged 
including specialized courts for DWI, Mental Health, Domestic Violence and others.   
The different courts that have emerged from this movement, including drug courts, seek 
to solve social problems using the principals of Therapeutic Jurisprudence applied in a variety of 
ways in a variety of circumstances.  In the case of drug courts, there is a commonality with other 
problem solving courts in that cases brought before these courts require the courts not just 
resolve disputed issues, but also attempt to solve a variety of human and social problems that are 
responsible for bringing the case to court (Winick, 2002).  With regard to drug courts, the 
problems to be addressed are mainly addiction and societal disconnection that have led to 
patterns of criminal involvement and ongoing interactions with the judicial system.  These courts 
grew out of a realization that traditional approaches such as three strikes and stringent sentencing 
guidelines had failed to have the impact that policymakers had hoped.   
In response to the failure of courts to actually reduce addiction, recidivism and criminal 
behavior, the framework of Therapeutic jurisprudence offered a new option for attacking the 
roots of these problems rather than simply “locking them up and throwing away the key.” The 
new problem solving courts are all characterized by ongoing, active judicial involvement, and 
the explicit use of legal authority to motivate participants to avail themselves of needed 
services—at least in the eyes of the judicial system—and to monitor their compliance and 
progress (Winters, Fals-Stewart, O'Farrell, Birchler, & Kelley, 2002).  The key components of 
drug courts reflect this approach and go a long way towards codifying what Therapeutic 
Jurisprudence is within the context of drug courts.  Dorf & Sabel (2000) describe this approach 
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as “experimentalist institutions” that point one way beyond the conventional limitation of courts 
and other institutions. 
Drug courts also represent a unique interaction between centralized and localized 
authority that has been a hallmark of Therapeutic Jurisprudence.  While the drug court 
movement can certainly be seen as nationwide, judged by the proliferation throughout the 
country and world, the workings, interventions and operation are uniquely customized at the 
local level.  This localization, and even customization, of drug court programs means that even 
factors such as a judge’s personal style can impact the effectiveness of the Therapeutic 
Jurisprudence model.  In support of this notion, a study by the NDCI found that better outcomes 
were produced, for example, by drug courts that had moderately predictable sanctioning 
schedules, exercised greater leverage over their participants, and had judges with more positive 
interactional styles (“Drug Court Review”, 2015).  This frequent drug court “customization” and 
dependency on personnel is a challenge to drug court research that will be discussed further in 
Chapter 5. 
No social work discussion of Therapeutic Jurisprudence would be complete without an 
examination of human rights and the rights of the individuals participating in drug court 
programs.  It has been debated as to whether Therapeutic Jurisprudence ought to be neutral (a 
theory) or normative (a philosophy) (Birgden, 2015).  The commitments of social work to the 
concept of self-determination is well documented in the National Association of Social Workers 
(NASW) Code of Ethics.  However, it should be noted that the rights of self-determination even 
within the NASW code are not absolute.  The NASW Code states that “Social workers may limit 
clients’ right to self-determination when, in the social workers’ professional judgment clients’ 
actions or potential actions pose a serious, foreseeable, and imminent risk to themselves or 
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others” (NASW Code of Ethics, 2015).  Does this code include the scope of work in drug courts 
that can be seen by many as paternalistic?  This author would argue that in a blended system like 
that of drug courts, drawing on numerous disciplines each with their own code of ethics, that no 
single professional code of ethics will be fully represented.  This is inherent to social work in any 
setting, and indeed, any professional code of ethics (Senjo & Leip, 2001). 
Life Course Theory 
One challenge in assessing the characteristics of effective drug courts is the lack of a 
theoretical framework for their initial design and implementation (Shaffer, 2011).  A laser like 
focus on efficacy is understandable from a policy standpoint. But, beyond understanding whether 
specialized court programs ‘work’, it is important to understand the mechanisms and theoretical 
explanations for why they work (Kaiser & Holtfreter, 2015).  Life Course Theory offers a 
theoretical framework to understand why drug courts work and what factors of the drug court 
intervention should be emphasized and studied.  As reviewed earlier in this chapter, there has 
been a wealth of study on “if drug courts work”, but far less study on the question of “why they 
work”.  By viewing the drug court intervention through the prism of Life Course Theory, we can 
begin to ask informed questions about the elements of it and elements of the participants to gain 
a richer understanding of the mechanisms by which drug courts get results. 
Generally, Life Course Theory aims to connect the social meanings of age throughout the 
lifespan, the intergenerational transmission of social patterns and the effects of social history and 
social structure to study human behavior over time (Newburn & McLaughlin, 2010).  The theory 
concerns itself with structural factors such as poverty or racism and how those affect the 
development of social bonds.  In other words, the Life Course perspective integrates the micro 
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and macro factors to explain criminal behavior in a way that uses sociological, psychological and 
aspects of human agency that are particularly compatible with social work.  Another hallmark of 
Life Course Theory in the context of criminal behavior is the labeling process (Newburn & 
McLaughlin, 2010) that can lead to accumulating disadvantage over the course of the lifespan.   
Life course research describes and explains constancy and modification in behavior or 
over time, and life course study often focus on the timing, order, and degree of life events and 
their influence on social development. Biological, psychological, cognitive, and social 
developments occur on different time scales, each with their own significant transitions and 
turning points (Halfon & Hochstein, 2002).  This approach holds that life experience and 
behavior can be understood by taking into context how a particular life trajectory came to be, and 
how criminal behavior and drug use (with its intertwined biological, social and psychological 
components) can influence offenders’ behaviors and decision making.   
Trajectories, transitions, and turning points are key concepts in life course research (Hser, 
Longshore, & Anglin, 2007).  The primary aspect with which this study concerns itself is drug 
court as a structural turning point (Newburn & McLaughlin, 2010; Elder Jr & Giele, 2009; 
Green, 2010) in the lives of offenders that can substantially alter future trajectories.  Sampson & 
Laub (2003) found that job stability or marital attachment factors in adulthood were significantly 
related to changes in adult criminal behavior—the stronger the adult’s ties to work and family, 
the more likely an individual was to desist from criminal behavior.  Social-control variables play 
a key role in explaining desistence from crime and substance use among adult offenders 
(Gottfredson, Kearley, Najaka, & Rocha, 2007).  More specifically, strong social bonds to the 
family and labor force were predictive of less crime and deviance among both delinquents and 
nondelinquents (Gottfredson, Kearley, Najaka, & Rocha, 2007).  Short of these social control 
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variables and bonds to normative society, individuals have been dubbed “life-course persisters” 
(Sampson & Laub, 2005) will continue to offend, use drugs and make choices that have them 
continually involved in the criminal justice system.  These social controls, coupled with daily 
routine activities that change from the unstructured to a routine filled with prosocial 
responsibilities, helps foster a shifting in priorities away from deviancy towards conformity or 
‘desistance by default’ (Barak, 1998).  This author would argue that drug court is a disruptive 
factor of the life course that fosters just that sort of turning point compatible with Life Course 
Theory.   
Although most of the research relating social bonds to desistence from crime and 
substance use has focused on the importance of family and work as sources of social control, 
theorists have suggested the importance of other opportunities for encouraging strong social 
bonds. Sampson and Laub (1993) theorized that extended periods of incarceration potentially 
reduces social bonds and might increase subsequent offending.  They recommend that 
alternatives to incarceration be used with offending populations, especially if these alternatives 
include elements likely to increase attachments to the social order. Drug courts represent just 
such an alternative. Put differently, locking them up and throwing away the key may not be the 
best approach if the goal of the criminal justice system is to actually address root causes of 
substance abuse and crime.  A less punitive approach, operationalized in problem solving courts, 
may be the way to better address crime and substance abuse. 
Social Capital Theory 
 A brief discussion of Social Capital Theory is appropriate at this point as the notions of 
the choices individuals make in the context of the life course can be linked to the idea of social 
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capital.  That is, one may consider that acquired social capital is a necessity for attainment of 
certain life milestones (in this case consider achieving abstinence and drug court graduation).  
Therefore, the more social capital one acquires, the more resources (financial, emotional, 
cultural) that person would have to devote to attaining drug court graduation.  The first 
systematic analysis of Social Capital was produced by Pierre Bourdieu who defined the concept 
as “the aggregate of the actual or potential resources which are linked to possession of a durable 
network of more or less institutionalized relationships of mutual acquaintance or recognition” 
(Portes, 2000).  Taking Bourdieu’s theory and applying it in the setting of drug courts requires 
some thought as to how social capital is acquired.  By accepting a new set of norms via factors 
like socially connecting, severing connections to criminal culture and positive interactions with 
the judicial system, drug court participants build social capital apart from their previous networks 
and associations.  Leveraging and accepting this new social capital and new social norms would 
then allow these individuals to move forward with life changing consequences.   
It could be argued that criminal behavior has an inverse relationship with social capital 
“since social capital reflects the existence of cooperative norms, social deviance ipso facto 
reflects a lack of social capital” (Fukuyama, 2001; May, 2008).  An excellent expression of 
social capital perspective in a drug court setting comes from (May, 2008) when she expresses the 
concept that individuals who are engaged in social networks that normalize substance use have 
“access to social capital that enables them to abuse or continue abusing substances”.  The social 
capital in this setting, May argues, is access to substances, a culture of substance use, and 
normalcy about addiction, substance use, and criminal behavior. Therefore, upon release from 
incarceration or while on probation or parole, drug offenders re-engage in social networks that 
enable and foster maladaptive behavior. Hence, drug court immerses (and compels) individuals 
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to develop new forms of social capital based on normative behavior and new social bonds which 
build ‘socially acceptable’ social capital via activities like employment, abstinence and 
connection to the mainstream economic culture of non-offenders. 
When thinking in terms of Social Capital Theory, drug courts can be seen as “factories” 
that manufacture social capital.  By providing access to services such as education, healthcare, 
employment assistance, housing assistance and positive, abstinent social interactions, these 
courts assist participants in building social capital.  Ties to other, maladaptive social networks 
are weakened and, in a combination of their own agency and decision making coupled with 
compulsory/enforced rules and norms, change is achieved.  Forming a new peer group, new 
social connections and changing the patterns of addiction are all ways in which new social 
capital is built.  “The result is access to social capital that encourages conventional, prosocial 
behaviors and facilitates an enhanced quality of life” (May, 2008).  
Recovery Capital Theory 
 The theoretical construct of Recovery Capital (Cloud & Granfield, 2008) attempts to 
expand upon the idea of social capital in a context more narrowly defined to apply to individuals 
in recovery from substance use disorders.  It can be understood by viewing it in the more familiar 
context of risk and protective factors frequently used by clinicians in diagnosing and treating 
those with substance use disorders.  The components of Recovery Capital as defined by Cloud 
and Granfield (2008) are: 
 Social Capital 
 Physical Capital 
 Human Capital 
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 Cultural Capital 
Social Capital in the context of Recovery Capital hews close to the definition in the widely used 
notion of the theory.  In essence, those with more Social Capital have group membership and 
other resources to help improve their situation in a crisis (such as a substance use disorder).  
Physical Capital in this context can easily be understood in terms of wealth and economic 
resources.  Human Capital embodies a wide range of individual attributes that provide one the 
means to function effectively in contemporary society (Cloud & Granfield, 2008).  This Human 
Capital may include knowledge, skills, Education mental health and other socially acquired 
traits.  Finally, Cultural Capital includes values, beliefs, dispositions, perceptions and attributes 
that emanate from membership in a particular group (Bourdieu, 1984). 
 Taken together, these attributes and their interaction in Recovery Capital Theory are a 
way to more specifically understand substance use disorder recovery in the context of Social 
Capital theory.  Drug courts can assist with the acquisition of Recovery Capital in the same ways 
as described for Social Capital theory above.  A way to conceptualize Recovery Capital in the 
context of drug courts is to think of the drug court participants as building Social Capital that can 
in turn foster recovery capital (Neale & Stevenson, 2015).  Cloud & Granfield (2008) point out 
that, ironically, access to the kinds of resources that constitute Recovery Capital are the very 
resources that would allow individuals to access treatment and services prior to an admission to 
drug court.  Consequently, a drug court can often be a resource of last resort for those who via 
life circumstance or via substance abuse have never gained (or lost previously held) Recovery 
Capital. 
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Conceptual Model 
 The complex systems interacting with the individual are so open to numerous variables 
that attempting to understand how to conceptualize the Life Course in understandable terms can 
be a daunting task.  Figure 2.1 simplifies Life Course Theory in such a way as to understand how 
variables interact with each other to affect an individual’s life course, bending it towards or away 
from certain behaviors and actions.  Referring to the figure below, this study conceptualizes an 
individual’s life course as straddling a line between adaptive, socially compliant behavior (the 
top half of the figure) and maladaptive criminal behavior (the bottom half of the figure). The 
downward arrow on the top represents factors that may push individuals towards lower, 
maladaptive side and the upward arrow represents factors that would influence a life course 
towards social connectedness and abstinence.  This study’s premise holds that factors in the 
upward arrow are stressed and reinforced by drug courts and are an influence (or “encouraging a 
turning point” in Life Course parlance) that would push an individual more towards socially 
accepted behavior and reduce the influence of potentially negative influences and traits. 
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Figure 3.3 Conceptual Model 
 
This model is a starting point for examining factors relating to drug court success.  It is a 
given that no one particular life is completely on either side of social connectedness or criminal 
behavior—the model is more of a guideline for conceptualizing how factors influence moving in 
and out of these realms than as an absolute understanding of the life course.  The variables 
selected in Chapter Three of this study reflect the thinking behind this model. 
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Conclusion 
 While drug courts have been subject to much scrutiny in terms of efficacy, much of the 
literature (and virtually no literature in social work) fails to provide a coherent, theoretical 
framework for how to understand them.  By applying a Life Course Perspective and layering that 
with an understanding of drug courts as builders of social and recovery capital, we can begin to 
winnow down elements that appear to be major influencers on the success of drug court 
participants.  By building the knowledge base in this way, the proven results and cost 
effectiveness of drug courts can be coupled with an evidence-based and theoretically grounded 
approach.  Chapter three expands upon the theoretical base by isolating factors to be studied in 
drug courts and making an attempt to statistically link those factors with drug court graduation. 
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Chapter 3:  Methodology 
 The goal of this research project is 1) to contribute to the general knowledge base of drug 
courts by identifying factors that contribute to success in drug court programs, 2) statistically test 
factors that are supported by theory and the literature as potential contributors to success in drug 
court programs, and 3) examine the drug court experience at different time points to find if there 
are potential risk and protective factors that may aid drug court professionals in identifying areas 
upon which they should focus their efforts during the course of drug court treatment and 
services.  The overarching research question of this study is:  What factors contribute to success 
(as defined by graduation) in a drug court program? 
To attempt to answer these questions, 3 analyses will be performed: 
1. What is the impact of race, gender, age, abstinence from drug use, employment, housing 
stability, having children, attendance at self-help group days, and educational level 
(measured at intake) on graduation? 
2. What is the impact of race, gender, age, abstinence from drug use, employment, housing 
stability, having children, attendance at self-help group days and educational level 
(measured at intake) on presence in the drug court program until the six-month mark? 
3. What is the impact of race, gender, age, abstinence from drug use, employment, housing 
stability, having children, attendance at self-help group days, and educational level 
(measured at the six-month time point) on graduation? 
While these questions look at identical factors, the different time points for questions one and 
two will allow for an assessment that goes to screening of drug court participants and warning 
signs to look for as potential stumbling blocks for participants.  In question one, the dependent 
variable of graduation will allow the study to tease out potential factors to look for prior to the 
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drug court intervention which may assist in screening for good candidates with a high probability 
of success and help identify candidates that may need additional services to optimize chances for 
graduation.  Question 2 with the dependent variable of making it to the six-month mark asks a 
similar, but more specific question as to factors leading to retention (a prerequisite to graduation) 
in the program.  Finally, Question 3 is one which will shed the most light on the intervention 
itself.  Question 3 is at a point where the vast majority of participants have secured employment 
(as required by the RADTC) and a point where they are fully invested in the program and are 
likely to be receiving the full spectrum of services.  By assessing factors at the six-month point in 
the program with graduation as the dependent variable, this question is the most germane with 
regard to impact of the program services themselves.   
The GPRA Instrument 
 The Government Performance and Results Act (GPRA) is the legislative framework that 
requires federally funded programs to define and report performance objectives (Darby & 
Kinnevy, 2010).  At its foundation, GPRA was an effort in the early years of the Clinton 
Administration in attempting to streamline and make government programs more accountable to 
taxpayers.  The premise was taken from Osborne & Graebler’s (1992) Reinventing Government 
(Darby & Kinnevy, 2010; Osborne, 1993).  The notion behind the act was to create quantitative 
and systematic data gathering allowing for an improvement in program outcomes and 
measurable program benchmarks allowing for more efficient use of government funding.  
Numerous government agencies were required to develop measures to comply with the GPRA 
legislation.  Groups formed under SAMHSA’s direction identified demographic information and 
five co-occurring treatment domains to be measured and reported to congress.  The result of this 
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effort was the CSAT GPRA Client Outcome Measures for Discretionary Programs (referred to as 
the GPRA Instrument in this study).  The GPRA Instrument is attached as Appendix 2 of this 
study. 
 The site of this study (RADTC) was the recipient of a targeted capacity expansion grant 
for their drug court site.  As a requirement of the grant, the GPRA Instrument was required to be 
administered to all drug court participants receiving services under the grant.  The instrument is a 
structured interview consisting of approximately 200 questions that, as a requirement for grant 
funding, was given at several time points: intake, six months, twelve months and upon discharge 
from the program.  The interviews were conducted by drug court clinical staff and others under 
their supervision.  Participation in the GPRA Instrument evaluation was completely voluntary 
and all participants were required by SAMHSA and the program to review and sign informed 
consents prior to participating.  The participants were informed of their right to withdraw from 
the evaluation at any point and all interviews were kept strictly confidential.  In keeping with the 
ethical requirements for use of this data, the next section of this study briefly outlines Human 
Subjects Protection for this study. 
Data Set 
 The data set being utilized for this study will be retrieved from the Services 
Accountability Improvement System (SAIS).  Once the GPRA Instrument is administered to 
participants, it is then entered by program staff into the SAIS online system.  While the 
instrument does contain demographic information such as age, race and gender, there is no 
directly identifiable information collected.  No names were captured and no readily available 
identifiers such as social security numbers are used (a randomly assigned study ID is used to 
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match cases).  In addition, the subjects involved in this study gave informed consent at the time 
of interview and were continually offered the option to withdraw.  Further, all subjects for whom 
data will be used have since graduated or otherwise separated from the RADTC program so there 
is no way in which use of this data could affect their progress in the program.  Taking into 
account the fact that data is de-identified with the fact that, at a minimum, all program 
participants have been separated from the program for a minimum of two years, it is anticipated 
that use of this data will cause no harm to those whose data is being utilized.  With the preceding 
facts in mind, this project was deemed “No IRB Necessary” by the VCU School of Social Work. 
 Data for this study was collected starting in March of 2011 with the last interview being 
conducted in October of 2013.  The total n=209 counting all of the interviews ranging from 
intake to discharge.  The breakdown by interview type is as follows: 
● Intake Interviews n=128 
● Six Month Follow Up n=73 
● Discharge Interview n=8 
The data set consists of over 225 variables corresponding to the answers in the GPRA 
Instrument.  The variables used for this study have been selected based upon grounding in the 
theories discussed in Chapter 2 and upon a review of the literature.  A breakdown of the 
variables for each research question of this study is illustrated in Table 3.1 below. 
Secondary Data Analysis 
 The present study design employs quantitative data methods in a correlational design that 
attempts to test if relationships suggested by theory occur (Drake & Jonson-Reid, 2008).  The 
study utilizes objective measures using statistical controls to test the association of multiple 
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variables to outcomes.  By utilizing secondary data, this study is able to cover a period of time in 
a lengthy drug court process (as much as two years in some cases) that may not normally be 
possible for a dissertation.  A common criticism of use of secondary data is that there may be 
information or questions that would ideally be asked in primary data collection that are not 
available in the secondary data source.  However, this author has attempted to ground the 
exploration in theory and previous drug court study in a way that makes the available data 
relevant, useful and viable.  Vartanian (2010) argues that “in many ways, users of secondary data 
trade control over the conditions and quality of the data collection for accessibility, convenience 
and reduced costs in time, money and inconvenience to the participants” (p 16).   
While secondary data is most often associated with large-scale, national data sets, in this 
case the secondary data allows this author to avoid costs and time investment that would make 
this research project impossible if only able to use primary sources.  Sample sizes are usually 
larger for secondary data sources, this is not always the case (Vartanian, 2010).  When looking at 
specific subpopulations (in this case the universe of individuals in drug court), there is not a 
readily available large data set ready for use.  Consequently, secondary data in the case of this 
study helps to shed light on a smaller group of individuals and follow them longitudinally using 
evaluation data collected for other purposes.  Secondary data may also subvert the process by 
“driving the question” or only creating questions that can be answered by the available data 
(Vartanian, 2010).  This leaves this researcher, in this case, with a cost/benefit analysis to make 
in terms of use of secondary data.  The ability to view a population of interest over time in a 
unique setting is what made use of secondary data for the present study useful and enlightening. 
The value of data collected by SAMHSA for the purposes of governmental reporting can 
shed light on an important, emerging trend in criminal justice.  This author has judged that use of 
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secondary data in this study can help to answer important questions on aspects which lead to 
drug court success.  The limitations in the use of secondary data will be addressed by use of 
statistical controls that will quantify relationships between multiple variables and demonstrate 
whether or not sample sizes available are sufficient to demonstrate those relationships.  As time 
goes on, it is possible that secondary data sources for drug court will grow, but as of this writing 
these limitations, not uncommon in the social sciences, must be acknowledged as existing in real 
world situations. 
Data Analysis Plan 
Variables 
 
 The dependent variable for research questions one and three of this study is graduation 
from the drug court program.  Graduation is an output measure simply defined as successful 
completion of the drug court program and is a dichotomous variable of yes or no (see Chapter 5 
for a discussion of graduation as an outcome).  For question 2, the dependent variable is also 
dichotomous yes or no as to whether the participant was still in the program (retention proxy) at 
the six-month mark of the program.  Consequently, the nature of the study will purposively 
assign drug court participants into groups for each question (Graduated and Not Graduated for 
Research Questions 1 and 3 and Enrolled and Not Enrolled at Six Months for Question 2). 
 The independent variables are the same for each question.  Table 3.1 below outlines the 
breakdown of the research questions along with variables matrix. 
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Table 3.1 Research Questions and Variable Matrix 
Overarching 
Research Question 
Dependent 
Variables 
Independent 
Variables
Variable Name 
RQ1:  What is the 
impact of race, 
gender, age, 
abstinence from drug 
use, employment, 
housing stability, 
having children, 
attendance at self-
help group days and 
education level at 
intake on graduation? 
Graduation   Race 
Gender 
Age 
Abstinence 
Employment 
Housing Stability 
Children 
Self-Help Group 
Attendance Days 
Education Level 
 
Graduation- 
Dichotomous Yes/No 
 
1:  Race 
2:  Gender 
3:  Age 
4:  Abstinence 
5:  Employment 
6:  Housing Stability 
7:  Children 
8:  Self-Help Group   
     Attendance Days 
9:  Education Level
RQ2:  What is the 
impact of race, 
gender, age, 
abstinence from drug 
use, employment, 
housing stability, 
having children, 
attendance at self-
help group days and 
education level on 
remaining in the drug 
court program until 
the six month mark? 
Enrolled at Six 
Months 
Race 
Gender 
Age 
Abstinence 
Employment 
Housing Stability 
Children 
Self-Help Group 
Attendance Days 
Education Level 
 
Graduation- 
Dichotomous Yes/No 
 
1:  Race 
2:  Gender 
3:  Age 
4:  Abstinence 
5:  Employment 
6:  Housing Stability 
7:  Children 
8:  Self-Help Group   
     Attendance Days 
9:  Education Level 
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RQ3:  What is the 
impact of race, 
gender, age, 
abstinence from drug 
use, employment, 
housing stability, 
having children, 
attendance at self-
help group days and 
education at the six 
month time point on 
graduation? 
Graduation  Race 
Gender 
Age 
Abstinence 
Employment 
Housing Stability 
Children 
Self-Help Group 
Attendance Days 
Education 
 
Graduation- 
Dichotomous Yes/No 
 
1:  Race 
2:  Gender 
3:  Age 
4:  Abstinence 
5:  Employment 
6:  Housing Stability 
7:  Children 
8:  Self-Help Group   
     Attendance Days 
9:  Education 
 
 The analysis will consist of a discriminant function analysis (DFA).  Discriminant 
function analysis is used to determine which continuous variables discriminate between two or 
more naturally occurring groups (Poulson & French, 2008).  The primary usefulness of DFA is 
to determine whether or not the combination of predictors can reliably predict group membership 
(Tabachnick & Fidell, 2013).  DFA also provides the ability to analyze the complexity of the 
variables and the interrelatedness of the variables simultaneously (Dattalo, 1995).  DFA 
automatically determines some optimal combination of variables so that the first function 
provides the most overall discrimination between groups, the second provides second most, and 
so on (Poulsen & French, 2008).  The ability to examine these multiple variables in one analysis 
is another reason the DFA is appropriate for this study.  Logistic regression was considered as a 
possible analysis for this study, however, the more demanding nature with regard to N make 
DFA a more useful procedure with this particular data set.  Consequently, DFA was determined 
to be the most appropriate statistical procedure for use with this data set. 
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Conclusion 
 The purpose of this study is to identify factors leading to success in drug court programs.  
Knowledge of how the influence of the key components of drug court coupled with inherent 
demographic traits participants impacts success is addressed, but not nearly in enough depth in 
the extant literature.  Grounding in theory, while present in scattered studies, takes a back seat to 
analysis of policy and overall general analysis of drug court impact.  By examining selected 
aspects of the drug court intervention and participants, the expectation of this study is to arrive at 
success factors that can be further focused in future research in this and other drug courts to 
arrive at more generalizable conclusions.  By gaining this knowledge, this author hopes to 
contribute understanding of factors influencing success in drug court in a way that will address a 
massive societal problem and better serve the needs of drug court participants.   
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Chapter 4:  Results 
Introduction: 
 This study focused on the impact of various demographic attributes of drug court 
participants along with some elements common to drug courts and assessed the impact of these 
variables on graduation from drug court.  As a secondary question, the impact of these 
demographic attributes and drug court program elements were assessed to gauge their impact on 
remaining in a drug court program.  The questions examined for this study are: 
1. What is the impact of race, gender, age, abstinence from drug use, employment, housing 
stability, having children, attendance at self-help group days, and educational level 
(measured at intake) on graduation? 
2. What is the impact of race, gender, age, abstinence from drug use, employment, housing 
stability, having children, attendance at self-help group days and educational level 
(measured at intake) on presence in the drug court program until the six-month mark? 
3. What is the impact of race, gender, age, abstinence from drug use, employment, housing 
stability, having children, attendance at self-help group days, and educational level 
(measured at the six-month time point) on graduation? 
 
Prescreening Data 
 Prior to data analysis, this data set was prescreened for the following factors:  absence of 
data errors; data completeness; absence of multicolinearity; multivariate normality; absence of 
outliers; linearity; and homoscedasticity.   
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 Data Completeness.  This data was prescreened for missing values in the Statistical 
Package for the Social Sciences (SPSS) 23.  Data was recoded with missing data coded as 1 and 
all other values coded as 0.  The three identified categories for missing data are missing 
completely at random (MCAR), missing at random (MAR) and missing not at random (MNAR) 
(Little & Rubin, 2014) .  In this particular data set, missing data can most likely be attributed to 
keying errors by drug court staff and/or incorrect completion of the GPRA interview by drug 
court staff. 
In this study, a bivariate correlation was produced to assess missing data.  The matrix 
produced a Pearson’s r value of less than .05 in all cases except for the variables of 30 Day 
Abstinence and Children.  These two variables had a perfect correlation for missing data.  Both 
of these variables had 1 case of missing data each.  Other than the possibility of keying errors 
and/or errors in conduction of the interview, no particular reason for this correlation was 
immediately evident.  In this case, it was determined that a missing data substitution was not 
appropriate in this situation (P Dattalo, personal communication, July 11, 2016).  Consequently, 
the correlation analysis suggests this data set should be defined as missing not at random 
(MNAR). 
Outliers.  Data was also screened for outliers using the Cook’s distance measure D 
(Cook’s D) in order to detect the impact of outliers in this data set.   Cook's distance addresses 
the question: How much change will there be in the parameter estimates if a specific data point is 
removed? Data points for which the answer is "a great deal of change" are said to be influential 
(Lorenz, 1987).  For this study, a Cook’s D screening was run on the models for all three 
research questions.  The Cook’s D cutoff for this study was determined by using the N of the 
sample for each research question then dividing 4 by sample size. 
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Question 1:  4/128 = cutoff of .03125 (4 cases deleted) 
Question 2:  4/128 = cutoff of .03125 (6 cases deleted) 
Question 3:  4/73 = cutoff of .0548 (6 cases deleted). 
Absence of multicolinearity.  For this study, an examination of bivariate correlations 
among independent variables for each research question was conducted.  The results were as 
follows: 
Question 1:  No Pearson’s r value was greater than .50 for any pair of IV’s 
Question 2:  No Pearson’s r value was greater than .50 for any pair of IV’s 
Question 3:  No Pearson’s r value was greater than .50 for any pair of IV’s 
 Homoscedasticity.  Homoscedasticity is the assumption that the variability in scores for 
one variable is equal at all values of another variable (Dattalo, 2013).  Homoscedasticity can be 
evaluated by examination of a plot of standardized predicted values as a function of standardized 
residual values (Dattalo, 2013).  For this study, plots of residuals versus predicted values were 
reviewed to determine if residuals were a function of predicted values.  A scatterplot, histogram 
and p-plot were examined for each research question’s data sets.   
 For questions 1 and 2, the resultant analysis was that the data exhibits low 
heteroscedasticity  
 For question 3, the figures demonstrated moderate heteroscedasticity 
Most researchers consider DFA to be robust against moderate violations of this assumption. 
The ideal is for an even distribution or a normal distribution depending on the graph (P. Dattalo, 
personal communication, June 30, 2016).  However, it should be noted that a violation of 
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homoscedasticity can make it difficult to estimate the standard error and usually results in 
standard error estimates that are either too large or too small (Dattalo, 2013).  While this must be 
taken into account for the data analysis, the robustness of DFA to moderate violations were 
deemed satisfactory to proceed. 
Sample Size/Power Analysis 
 A power analysis was conducted in G Power (a widely used freeware power analysis 
software) to determine minimally accepted sample sizes for this study.  Power is the probability 
of rejecting the null when a particular alternative hypothesis is true (Dattalo, 2008).  Put simply, 
a power analysis allows the researcher the confidence to determine if the representative sample 
of a population being studied does actually represent that population.  Due to a multivariate 
analysis of variance (MANOVA) being mathematically equivalent to a DFA, an A priori 
MANOVA: Global Effects analysis was used for the G Power calculation.  The results of the 
power analysis are summarized in Figure 4.1 below. 
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Figure 4.1 GPower Sample Power Analysis 
 
Using a .15 effect size, an alpha of .05 and a power of .8 for the F tests G Power indicated that a 
minimally acceptable sample size for this analysis was 56.  The N of all three research questions 
meets the minimum sample size criteria. 
 Results from the screening procedures and power analysis were not considered a major 
barrier to proceeding with the discriminant function analysis (DFA), below. 
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DFA 
 Discriminant function analysis is used to determine which continuous variables 
discriminate between two or more naturally occurring groups (Poulsen & French, 2008).  DFA 
answers the question: “can a combination of variables be used to predict group membership?” 
Usually, several variables are included in a study to see which ones contribute to the 
discrimination between groups (Poulsen & French, 2008).  In the case of this study, the two 
groups are divided among the one dependent variable (Graduated or Not Graduated in the case of 
Questions 1 & 3 and Present in the Program at the 6 Month Mark or Not Present in the Program 
at the 6 Month Mark in Question 2).   
 As with the data screening process, the data was analyzed in the Statistical Package for 
the Social Sciences (SPSS) 23.  Three different DFA models (each corresponding to the three 
research question) were run to discriminate between 2 groups (as referenced in the preceding 
paragraph.  Box’s M was used to test the assumption that groups have equal variance-covariance 
matrices (Dattalo, 1995).   
Research question 1.  The two group DFA was used to determine which variables 
discriminate among the following groups: (1) graduated from the drug court program and (2) did 
not graduate from the drug court program.  The discriminating (independent) variables (taken at 
intake) were age, gender, race, 30-day abstinence, days in self-help groups, stability in housing, 
presence of children, educational level and employment status. 
 Box’s M was used to test the assumption (H0) of equality of variance-covariance 
matrices.  Box’s M equaled 58.450, F(2, 40237) = 1.18, p =0.182, which meets the assumption 
of equality of variance-covariance matrices.  The two group DFA yielded 1 discriminant 
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function.  This discriminant function had a canonical correlation of .493.  Wilk’s Lambda 
equaled .756, Chi square (9, N= 113) 29.722, p <.001.  Therefore, the H0 of no differences 
among the group centroids is rejected. 
 Overall, approximately 69% of the original grouped cases were correctly classified.  For 
the graduated group, approximately 64% were correctly classified.  For the not graduated group 
approximately 25% were correctly classified. 
 Standardized coefficients were used to compare a variable’s relative relationship to a 
function.  These coefficients are summarized by function in Table 4.1.  In terms of absolute size, 
for function one, the presence of children was most important, followed by employment status 
and 30-day abstinence.   
Structure coefficients were also used to compare a variables relationship to a function and 
are summarized in Table 4.2.  For this question, these coefficients are generally consistent with 
the standard coefficients. 
Standardized discriminating coefficients quantify the relationship between a particular 
discriminating variable and the discriminating function, while controlling for the effects of other 
discriminating variables. Structure coefficients quantify the relationship between a 
discriminating variable and the discriminating function. In other words, structure coefficients are 
bivariate, zero-order coefficients; standardized discriminating coefficients are standardized, 
partial coefficients (P Dattalo, personal communication, July 11, 2016).  Consequently, there 
may be an interaction between variables or another variable that is not accounted for in this 
model. 
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In summary, the model for research question 1 demonstrated a low to moderate ability to 
predict group membership with presence of children, employment and 30-day abstinence as the 
most important discriminating variables.  However, the function appears to have a moderate to 
low utility based on the canonical r of .493  
Research question 2.  The two group DFA was used to determine which variables discriminate 
among the following groups: (1) present in the program at the six-month mark and (2) not 
present at the program at the six-month mark.  The discriminating (independent) variables (taken 
at intake) were age, gender, race, 30-day abstinence, days in self-help groups, stability in 
housing, presence of children, educational level and employment status. 
 The Box’s M analysis returned an error stating that no test can be performed with fewer 
than two nonsingular group covariance matrices (indicating nonsingularity).  As this test is used 
to test the assumption (H0) of equality of variance-covariance matrices, no equality of variance-
covariance matrices can be assumed for this model.  This is likely due to the fact that, at the six-
month point, abstinence, presence at six months and employment have less variability across the 
groups, not allowing the variance assumed for this statistical procedure.  The two group DFA 
yielded 1 discriminant function.  This discriminant function had a canonical correlation of .495.  
Wilk’s Lambda equaled .755, Chi square (9, N= 111) 29.349, p =.001.  Therefore, the H0 of no 
differences among the group centroids is rejected. 
 Overall, approximately 78% of the original grouped cases were correctly classified.  For 
the present at six-month group, approximately 75% were correctly classified.  For the not present 
at six-month group approximately 8% were correctly classified. 
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 Standardized coefficients were used to compare a variables relative relationship to a 
function.  These coefficients are summarized by function in Table 4.1.  In terms of absolute size, 
for function one age was most important, followed by race and 30-day abstinence.   
Structure coefficients were also used to compare a variables relationship to a function and 
are summarized in table 4.2.  For this question, race was the most important with 30-day 
abstinence and education level being the next 2 highest effect sizes.  As stated above, the 
differences between the standardized and structure coefficients may be due to interaction or 
factors not accounted for in the model. 
In summary, the model for research question 2 demonstrated a low to moderate ability to 
predict group membership with age, race and 30-day abstinence as the most important 
discriminating variables.  As with the previous model, the function appears to have a moderate to 
low utility based on the canonical r of .495  
Research question 3.  The two group DFA was used to determine which variables 
discriminate among the following groups: (1) graduation from the program and (2) not graduated 
from the program.  The discriminating (independent) variables (this time measured at the six-
month time point) were age, gender, race, 30-day abstinence, days in self-help groups, stability 
in housing, presence of children, educational level and employment status. 
 As with research question 2, the Box’s M analysis returned an error stating that no test 
can be performed with fewer than two nonsingular group covariance matrices.  As this test is 
used to test the assumption (H0) of equality of variance-covariance matrices, no equality of 
variance-covariance matrices can be assumed for this model.  Much like question 2, this question 
also investigates effects of the independent variable at the six-month point.  Also similar to 
question 2 (due to program requirements) abstinence, graduation rates and employment have less 
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variability across the groups, not allowing the variance assumed for this statistical procedure.  
The two group DFA yielded 1 discriminant function.  This discriminant function had a canonical 
correlation of .576.  Wilk’s Lambda equaled .668, Chi square (9, N= 59) 21.146, p =.012.  
Therefore, the H0 of no differences among the group centroids is rejected. 
 Overall, approximately 78% of the original grouped cases were correctly classified.  For 
the present at six-month group, approximately 75% were correctly classified.  For the not present 
at six-month group approximately 9% were correctly classified. 
 Standardized coefficients were used to compare a variables relative relationship to a 
function.  These coefficients are summarized by function in Table 4.1.  In terms of absolute size, 
for function one race was most important, followed by self-help group days and presence of 
children.   
Structure coefficients were also used to compare a variables relationship to a function and 
are summarized in table 4.2.  For this question, race was the most important with 30-day 
abstinence and self-help group days being the next 2 highest effect sizes.   
In summary, the model for research question 3 demonstrated a low to moderate ability to 
predict group membership with race, self-help group days and presence of children as the most 
important discriminating variables.  The function appears to have a low utility based on the 
canonical r of .576.  
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Table 4.1  
DFA Standardized Coefficients 
Standardized Coefficients Summary of the Three Models 
 
 Model 1 Model 2 Model 3 
Children 0.635 -0.328 0.274 
Employment Status 0.409 -0.459 -0.493 
Race -0.404 0.600 0.778 
Education Level -0.222 0.270 -0.175 
30 Day Abstinence 0.360 0.425 -0.614 
Age -0.572 0.695 0.186 
Gender 0.028 -0.023 -0.212 
Stability in Housing 0.076 0.239 0.013 
Self-Help Group 
Days 
0.252 0.001 0.368 
Rc 0.493 0.495 0.576 
Wilk/s 0.756 0.755 0.668 
Table 4.2:  
Structure Coefficients Summary of the Three Models 
 Model 1 Model 2 Model 3 
Children 0.531 -0.475 0.031 
Employment Status 0.454 -0.435 -0.400 
Race -0.447 0.490 0.565 
Education Level -0.336 0.328 0.175 
30 Day Abstinence 0.246 0.205 -0.356 
Age -0.215 0.223 0.113 
Gender 0.201 -0.112 -0.056 
Stability in Housing 0.102 0.072 0.037 
Self-Help Group 
Days 
-0.013 0.072 0.362 
Rc 0.493 0.495 0.576 
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DFA 
Structure Coefficients 
 
   
Wilk’s 0.756 0.755 0.668 
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Table 4.3: 
Variable Detail for Models 1 through 3 
 
 
 
 
 
 
 
 
   
Variable Details for Models 1 through 3 
Model 
1 
Model 
2 
Model 
3 
Graduated  (present at 6 months for model 2)    
  Yes 51.60% 80.30% 66.20%
  No 48.40% 19.70% 33.80%
Gender    
  Male 56.50% 55.70% 53.70%
  Female 43.50% 44.30% 46.30%
Race    
  African-American 78.20% 77.90% 73.10%
  White 21.80% 22.10% 26.90%
Mean Age 38.23 38.13 38.8 
Median Age 39 39 40 
Self Help Group Days Mean 11.65 11.88 13.5 
Self Help Group Days Median 12 12 12 
30 Day Abstinence    
  Yes 76.40% 78.50% 95.50%
  No 23.60% 21.50% 4.50% 
Children    
  Yes 69.90% 68.60% 68.70%
  No 30.10% 31.40% 31.30%
Employment    
  Employed Full Time 1.60% 31.10% 62.70%
  Employed Part Time 30.60% 7.40% 3.00% 
  Unemployed, Looking For Work 44.40% 43.40% 13.40%
  Unemployed, Disabled 12.10% 11.50% 16.40%
  Unemployed, Volunteer Work 0.80% 0.80% 0% 
  Unemployed, Not Looking For Work 3.20% 4.10% 3.00% 
Education Level    
  Less Than High School 45.20% 45.10% 40.30%
  HS Diploma or GED 31.50% 31.10% 40.30%
  Technical School 4% 3.30% 3% 
  Some College 16.90% 18% 13.40%
  Completed College or Higher 2.40% 2.50% 3% 
Housing Situation    
  Own/Rent Apartment or Home 30.10% 29.80% 40.30%
  Someone Else's Home 31.70% 31.40% 38.80%
  Halfway House 2.40% 2.50% 7.50% 
  Residentail Treatment 16.30% 16.50% 6% 
  Homeless/Shelter 17.10% 16.50% 6% 
  Other  1.60% 2.50% 1.50% 
N 113 111 59 
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Chapter 5:  Discussion 
 Drug courts have been the subject of numerous studies that attempt to isolate their 
effectiveness, effects on recidivism, internal workings and their various isolated elements.  
Unfortunately, a small percentage of those studies are theory driven and/or comprehensive in 
scope.  For more than a decade, researchers have characterized drug courts as a ‘Black Box’ 
(Bouffard & Taxman, 2004; Goldkamp, White, & Robinson, 2001; Shaffer, 2011) that they have 
portrayed as a mysterious process that eluded understanding.  Drug courts have been accepted as 
a fact of life in jurisdictions throughout the nation (and the world) as a ‘better’ solution than 
traditional parole, probation and incarceration.  Through the establishment of drug courts judges 
in the U.S. have been the leaders primarily responsible for initiating the major shift in criminal 
justice policy and practice regarding drug offenders (Cooper, 2015).  There has not been a slow 
methodical rollout of these courts via legislation or public outcry.  Drug court expansion has 
been the result of the efforts of individuals on the ‘front lines’ of criminal justice as a reaction to 
a widespread feeling among many in the courts and law enforcement that the revolving door of 
drug arrests and incarceration had to, somehow, be interrupted. 
 The ballooning body of research on drug courts has grown to the point where the 
majority of literature endorses the effectiveness of drug courts, but not nearly enough researchers 
attempt to ask ‘why’ they work or ‘how’ they work.  Because drug courts, as an intervention, can 
vary widely from jurisdiction to jurisdiction, this author would argue that there is a significant 
‘treatment fidelity’ issue that bars fully understanding the phenomenon of drug courts as an 
overall intervention.  The increasing popularity of drug courts would seem to indicate that they 
are here to stay.  Policymakers on the local, state and national level as well as social workers 
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would do well to continue to expand the growing knowledge base regarding what ‘makes drug 
courts tick’ and to be able to point to well-reasoned, theory-based explanations for their success.   
 This study was conducted to attempt to gain an understanding, through the lens of theory 
and empirical support what inherent individual aspects of an individual and what major aspects 
of the drug court intervention contribute to success (defined as graduation for the purposes of 
this project) from drug court.  In addition, a secondary question asking how longevity in drug 
court (presence in the program at the six-month point) may be influenced by the same factors 
studied for influence on graduation.  This researcher has attempted to make this project unique 
by viewing the journey of an individual in drug court through the lens of several theories.  These 
theories are commonly used in social work, criminal justice and substance use disorder research, 
but combined take a combination of micro and macro approaches that are unique to social work 
and not explored in depth in the extant literature. 
 This chapter begins with an examination of the limitations of the data and an examination 
of the study findings.  Next, this chapter contains a discussion of the implications of these 
findings for social work and social justice and a discussion of the implications for social work 
education.  Lastly, this chapter ends with directions for future research.    
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Interpretation of the Data 
Limitations of the Data  
Graduation as Outcome.  Drug court graduation is an outcome upon which there is 
general agreement in the literature.  However, it must be acknowledged that the programs and 
requirements that lead to graduation from any particular drug court graduation may be different 
from court to court.  To accept that drug court graduation can be measured as an outcome, one 
must peer inside the ‘Black Box’ and come to an understanding of what graduation is a proxy for 
across drug courts.  Going back to the key principals of drug court outlined above, this researcher 
would argue that there are several items that can be universally agreed upon as part of a set of 
outcomes that lead to graduation.  Among the items that graduation is proxy for are: long term 
drug and alcohol abstinence (monitored via frequent, random testing); attainment of 
employment; and some form of drug treatment intervention (ranging from self-help groups to 
group and individual interventions).  Drug courts have become institutionalized enough and drug 
court training via national organizations is standardized enough to have led to graduation being a 
representation of a few agreed upon elements (the scope and intensity of which it must be 
acknowledged vary from place to place). 
 This study was conducted in the Richmond Adult Drug Treatment Court, the guidelines 
for which are available for review in Appendix 1.  However, it must be acknowledged that these 
guidelines were developed by the judge, practitioners, Commonwealth’s Attorney and other 
stakeholders in this local system.  There is a well-worn statement among individuals working in 
drug courts that “If you’ve seen one drug court, you’ve seen one drug court.”.  This variation and 
‘customization’ of drug courts as an intervention should be acknowledged, but this researcher 
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would argue that it is not an impediment to developing a global understanding of drug courts by 
examining a single drug court (at least as a first step).   
Limitations of the GPRA Instrument.  The GPRA Instrument (attached as Appendix 2) 
was designed as a reporting tool for federal drug court grantees to relay program information to 
federal funders.  The data collected is self-reported by drug court participants.  Consequently, 
some of the information collected is particularly sensitive in a drug court context.  As a central 
tenet of any drug court program being sobriety and abstinence, participants would very likely be 
reluctant to report alcohol and/or drug use.  While frequent testing can assist with verifying 
claims of abstinence, the self-interest of participants who are self-reporting drug and alcohol use 
must be acknowledged.   Another limitation of self-report in the GPRA are the items regarding 
attendance at self-help groups.  Self-help group attendance in the RADTC are another required 
element of the program.  While every attempt is made to verify attendance, it is another area to 
note where veracity of self-reporting clients and program requirements may bump up against 
each other. 
 Another item of note in the reporting of the GPRA data is that collection is a stepwise 
process involving completion of a paper interview instrument that is completed by drug court 
staff and then entered into the CSAT online system where it was then retrieved by this 
researcher.  As with any data entry keying errors, missing data and human error are pitfalls of the 
process. While SAMHSA provided extensive training resources to those managing GPRA data, 
it is likely a certain amount of error may occur in even the best situations.  This potential for 
error (which can have significant impacts when dealing with smaller sample sizes) is one which 
researchers should also acknowledge, but should not present a barrier to examination of that data. 
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Group Variability.  As drug court participants advanced through the program, items like 
attendance at self-help groups, employment, housing stability and 30-day abstinence tended to 
become more similar between cases as program requirements influenced the participants.  This 
likely affected the DFA models ability to accurately distinguish between groups and impacted 
the predictive ability of the statistical analysis.  This lack of variability is likely inherent in the 
design of this study due to the fact that only individuals sill engaged with the program are 
administered the GPRA interview.  As this was an analysis of secondary data (the pros and cons 
of which are addressed in Chapter 3), this was a side effect of working with the data available to 
this researcher. 
Data Analysis 
 This study examined three different research questions utilizing discriminate function 
analysis (DFA).  The results of the data and the models created suggested a low to medium 
ability of the models to predict group assignment based on the same group of independent 
variables being analyzed for contribution to graduation (with one model (1) examining the 
variables at intake and one model (3) examining the variables at the six-month time point).  The 
third model (2) examined the same set of independent variables at the six-month time point and 
attempted to predict group assignment at the graduation time point.  While the models presented 
low to moderate predictive ability, there is data to suggest important factors in drug court 
success.   
Models 2 and 3 performed slightly better than Model 1 as evidenced by the Wilk’s 
Lambda of the three models (Table 4.2).  Models 2 and 3 both involve comparisons using data at 
the six-month time point (for Model 2 a DV of presence in the program at six months and for 
Model 3 an examination of the IVs at the six-month time point with graduation as DV).  For 
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Model 3, one interpretation is that at the six-month time point, success in the program is much 
more likely.  That is, the vast majority of individuals have secured employment, attended 
meetings and attended court hearings.  However, children drop out of the largest effect sizes 
when comparing the IV’s at intake to presence at six months (Model 2).  Why presence of 
children seems to influence graduation, but not presence in the program at six months is another 
interesting question to study in the future.  The contribution of children to the factors studied in 
this project are addressed in more detail below. 
It is also interesting to note that for Models 2 and 3, the single most contributory factors 
for group assignment were age and race.  This is an interesting finding in that race and age are 
not a readily changeable status (like education, employment or group attendance).  The impact of 
race and age on success in drug court is discussed below in the Directions for Future Research 
section.  These findings are ones that bear additional inquiry in the future as it raises significant 
questions with regard to social justice and the cultural/ethnic competency of drug courts.  
Model 1 
 Influence of Presence of Children.  The largest contributor to graduation in Model 1 
was whether or not the drug court participant had children.  In the conceptual model presented in 
Chapter 2, this would be one of the items this researcher describes as social connectedness.  This 
was an interesting finding due to the fact that there is nothing in current literature discussing 
having children as a predictor of success.  There are studies that emphasize the fact that 
participation in drug treatment court does lead to reunification of families that have been 
separated due to a parent’s drug use and/or criminal history (Gifford, Eldred, Vernerey, & Sloan, 
2014; Levine, 2012).  This is obviously a desirable outcome for drug court participants and this 
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fact alone warrants further investigation of how drug courts impact the children of participants.  
In addition, there have been findings that women have better substance abuse treatment 
outcomes if they can regain custody of their children (Fischer, Geiger, & Hughes, 2007). 
 The notion of children being tied to success in drug court brings to the fore a type of drug 
court not addressed in this study, the family drug treatment court.  Family Drug Treatment 
Courts are another form of specialized, problem solving courts.  These courts provide the setting 
for a collaborative effort by the court and all the participants in the child protection system to 
come together in a non-adversarial setting to determine the individual treatment needs of 
substance-abusing parents whose children are under the jurisdiction of the dependency court 
(Edwards & Ray, 2005).  This finding could suggest that add on services such as onsite 
childcare, women’s focused interventions and the addition of family inclusive therapies may 
contribute to the success of drug courts in the long run. 
Employment Status.  The second most influential factor in group assignment in Model 1 
was employment status at intake.  Consistent with the framework of Social Capital and Recovery 
Capital, this would indicate that individuals who enter the program with some form of 
employment start with a ‘leg up’ in terms of having some Social/Recovery Capital upon entering 
the program.  This has implications that should be considered by drug court professionals. 
 For those without employment at intake, every effort should be made to secure 
employment for those individuals as early as possible.  With employment being a key 
requirement of the drug court program, this would seem obvious.  However, this finding would 
seem to indicate that those individuals without employment are at greater risk than those who are 
employed at intake.  By emphasizing employment opportunities, job training and resume 
building as a top priority in the earliest stages of drug court, those individuals entering ‘at risk’ 
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due to not being employed may enjoy more success in the program and be less likely to re-offend 
or relapse (leading to failure to graduate).   
 Those already employed at intake appear to represent the ‘low hanging fruit’ for drug 
court staff.  What must be avoided is ‘selecting for success’ and making sure that drug court 
participants are “met where they are” and have individualized treatment plans that prioritize 
employment for those not employed at intake.  A recent study by (Webster, Staton-Tindall, 
Dickson, Wilson, & Leukefeld, 2014) supports this view in its findings that showed that those 
who were on negative pre-baseline work trajectories assigned to individually tailored 
employment interventions in drug court were more likely to enter the workforce.   
  30 Day Abstinence.  At intake, 30-day abstinence has not been monitored by weekly 
drug testing.  At every other time point, abstinence and sobriety are ‘baked in’ to the program 
using random drug testing.  This author would argue based on the review of numerous drug 
courts that abstinence is one of the single most (if not the most) emphasized and tracked aspect 
during the participant’s entire time in drug court.  While further research documenting drug court 
sanctions would be needed to bear this out, it is inarguably central to all drug court programs.  It 
makes intuitive sense that abstinence is a large factor contributing to success, but documentation 
of how drug courts handle the common substance use disorder symptom of relapse (discussed 
below in the Directions for Future Research) is another item that would bear further 
investigation.  Specifically, more intensive scrutiny of abstinence history at intake versus 
abstinence at other program time points would be an informative investigation. 
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Model 2 
Age.  There are a number of studies that point to age as a predictor of success in drug 
courts (Butzin, Saum, & Scarpitti, 2002; Deschenes∗, Ireland, & Kleinpeter, 2009; Rempel et al., 
2003).  However, this author was unable to locate studies that looked at influence of age at the 
six-month time point.  The evidence of this study and the extant literature do support the idea 
that age is an influence on drug court success.  A further understanding of this connection 
(perhaps through qualitative study) might shed some additional light on why this factor is found 
to be a common influence. 
Race.  Another worthwhile area of inquiry for drug courts would be to delve deeper into 
demographic aspects that contribute to success (or lack thereof) in drug courts.  There have been 
research questions exploring the impact of factors like race (Dannerbeck, Harris, Sundet, & 
Lloyd, 2006) and gender (Dannerbeck, Sundet, & Lloyd, 2002).  Studies like these have 
indicated differences of outcome between different groups in drug courts.  Tackling this issue 
would serve the dual purposes of better tailoring drug courts for diverse populations and the 
inherent social justice issues that already plague the justice system such as the over 
representation of minorities vis-à-vis the general population of the United States in jails and 
prisons.  In light of the findings of Models 2 and 3, this is an area of future study that should be a 
priority for drug court researchers. 
30 Day Abstinence.  30-day abstinence is discussed above with Model 1.  However, the 
reason why 30-day abstinence at intake would influence graduation and presence in the program 
at 6 months but not significantly predict from the six-month time point (as in Model 3 below) is 
not sufficiently addressed by this study.  This would be another connection wherein additional 
inquiry may address more completely 
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Model 3 
Race.  As discussed immediately above, this is a studied, but not understood factor in 
drug court success.  Understanding of race at any time point in the drug court process is a worthy 
subject of study going forward. 
Self-Help Group Attendance.  Model 3 indicated a correlation between days attended at 
self-help groups at the six-month time point with graduation.  However, the number required in 
phase one is not specified in the RADTC manual.  These findings suggest that, for those not 
already in the habit of attending groups, additional emphasis and perhaps additional meetings 
may be warranted.  The issue of what constitutes the necessary and sufficient ‘dosage’ of 12 step 
and other self-help groups is one that the data suggest may be worth exploring.  Most drug courts 
(as with the RADTC after phase I and into aftercare) specify a number of self-help groups 
participants should attend as part of their program.  It is possible that these numbers can be 
titrated for more at-risk participants to ‘even the playing field’ for those who enter the program 
with additional resources that may impact their success in drug court.   
Presence of Children.  This influencing factor is discussed above, however, why 
presence of children seems to influence graduation but not presence in the program at six months 
is not fully addressed by this study design.  Qualitative study and collection of more information 
on the living situation of children of drug court participants (i.e.; are they living with the 
participant, has there been a separation from parents by social services) are two ideas that may 
make for an interesting study. 
 70 
It should be noted that Model 3 is the strongest of the models examined.  It suggests that 
this six-month time period is an important one to study and that the relationships (particularly 
with 12 step group days) should be a priority for future studies. 
Implications for Social Work and Social Justice.  Drug courts began as a unique 
intervention to serve dual aims: to reduce the cost to the system of repeat drug offenders and to 
merge treatment and judicial supervision in a way that improved the lives of those in the legal 
system due mainly to substance use disorders.  On its face, the second aim of providing treatment 
instead of punishment for drug crimes is compatible with the aims of social justice and the 
mission of social work.  The idea of reducing costs and slowing the revolving door of 
incarceration that were the status quo of drug crimes are a helpful policy byproduct that assists in 
the proliferation of drug courts. 
 From a macro social work perspective, drug courts have been a policy intervention that 
have served to foster social justice for the people who have avoided jail time and improved their 
lives via participation in drug court programs.  Social workers must be aware of the personal 
agency of each individual participating in drug court and their right not to participate in drug 
court.  There have been Constitutional arguments with regard to due process in drug court 
(Hoffman, 1999).  The latitude judges are given in most drug courts may seem capricious and, in 
some cases, could be abused.  Drug courts have been described as “experimentalist” government 
(Dorf & Sabel, 2000) and, as such, should not be accepted without empirical evidence of their 
effectiveness and with an eye towards preserving the free will and inherent rights of those 
participating.  This author believes that the ongoing ‘laboratory’ of drug courts are a natural 
place for social workers and social work values.  The perspective and ethical code social workers 
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bring to the table in drug courts make us uniquely able to consider the larger policy implications 
of drug court while serving our clients. 
 From a micro social work perspective, social workers have long been on the front lines of 
treating individuals with substance use disorders.  The courts system is another arena in which to 
apply these skills.  Further, an estimated one third of drug court participants have co-occurring 
disorders (Peters, 2008).  Clinical social worker’s training in the diagnoses of behavioral health 
disorders are a natural fit for this setting.  There is also a place for the practice of “forensic social 
work”.  If one considers social work in corrections and probation, forensic mental health, 
substance abuse, family and criminal courts, domestic violence and child abuse and neglect, 
juvenile justice, crime victims, and police social work, we would realize that many in the 
profession are engaged in forensic social work (Roberts & Brownell, 1999).  It is time for social 
workers to embrace that role and develop it as way to merge micro and macro social work 
practice while seeking social justice. 
 There is a strong social justice argument to be made for drug courts.  They represent a 
paradigm shift towards treatment of those with substance use disorders in the criminal justice 
system.  As our understanding of substance use disorders broadens, we see it for what it is, a 
disease of the brain.  No one would seriously argue that a patient who sees a doctor for an 
infection should be punished if the first antibiotic prescribed does not cure the infection 
(Lessenger & Roper, 2008).  In much the same way, if we accept that substance use disorders are 
a disease, punishment for relapse should not be as dire as immediate incarceration.  Drug courts 
must, as part of their mandate, punish behavioral infractions.   However, most courts such as 
RADTC distinguish between actions that are behavioral and actions related to addiction.  In this 
 72 
way, criminal and or maladaptive behaviors can be modified as well as the disease of addiction 
treated. 
 There is additional work to be done with regard to drug courts on the social justice front.  
Social workers must advocate to ‘push’ the treatment vs. punishment paradigm along to other 
areas of society.  For example, individuals who have been charged/convicted of felony drug 
offenses will be denied (1) welfare benefits; (2) educational loans; (3) public housing; and (4) the 
right to vote (Cooper, 2015). Employment opportunities are also hampered by required 
disclosure of convictions and licensure and/or security clearance requirements that exclude 
persons with a record involving drug offenses. Further, (Cooper, 2014) points out that 
“deportation proceedings can be instituted – even for persons with legal immigration status -- 
based upon a drug charge, even one that was dismissed”.   
These problem solving courts are a way to tackle an intractable and growing social 
problem by trying something that is more strengths based, less punitive, more person centered 
and recovery oriented.  While there is an argument that there are issues of coercion involved in 
drug courts, the argument should be more properly framed as an alternative to simply 
warehousing those with substance use disorders in prison and jail.  With all of this in mind, this 
author would argue that drug courts are a natural fit for seeking social justice and for the ethical, 
productive practice of social work. 
Implications for Social Work Education. 
As drug courts continue to expand social work educators would be well served to 
emphasize the value of social work in criminal justice settings.  Seeking and encouraging field 
placements in the judiciary would benefit problem solving courts by bringing in more individuals 
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with the strengths based perspective that social workers bring.  Additionally, educating and 
employing more social workers can help bring a clinical rather than law enforcement or 
parole/probation perspective to judicial supervision.   
 To promote effective social work practice, the curriculums of schools of social work 
should reflect the changing face of the criminal justice population that include increased numbers 
of individuals with co-occurring substance use disorders and mental illness by including content 
on drug use, mental illness, and the consequences of these conditions on individuals within the 
criminal justice system. It is also suggestive that social work students should receive additional 
instruction on working with involuntary clients and their families to ensure they are competent to 
address the needs of this population properly and with competence (Tyuse & Linhorst, 2005). 
Directions for Future Research.   
It would be difficult to find a judicial/substance use disorder phenomenon that has been 
studied as much as drug courts have in the last two decades.  However, there are several areas 
ripe for further inquiry that would assist researchers in understanding the impact of these courts. 
 The understanding of what influences drug court outcomes would benefit greatly from 
further qualitative inquiry.  So much of the journey of individuals in drug court is a personal one.  
The voice of those experiencing the program itself (Wolfer, 2006) would be an invaluable tool in 
further theory development and in answering the question of ‘why’ drug courts work, not just the 
question of ‘if’ they work.  One major finding of qualitative studies done in drug courts has been 
that success in drug courts has been credited by many drug court participants to their interactions 
with the judge (Marlowe, Festinger, Lee, Dugosh, & Benasutti, 2006).  Understanding what 
makes these interactions effective, what the ‘dosage’ of judicial interactions should be, and 
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understanding what about the interactions is effective in the eyes of participants would greatly 
benefit drug court practitioners.  Further qualitative study may also allow for customization of 
drug court interventions that allow for better outcomes. 
 Additional long term recidivism data would also make a compelling case for the further 
institutionalization of drug courts.  There are studies in the literature that point to the long term 
effectiveness of drug courts in preventing recidivism (Finigan, Carey, & Cox, 2012), (Wilson, 
Mitchell, & MacKenzie, 2006), (Krebs, Lindquist, Koetse, & Lattimore, 2007).  While this sort 
of longer term research over the course of many years may not be practicable for a dissertation 
project, this kind of data collection combined with meta-analysis from multiple jurisdictions and 
multiple courts nationwide would be a worthwhile project for government agencies and larger, 
well-funded research groups.  This recidivism data would not only assist with the acceptance of 
drug courts as a policy intervention but also with the potential expansion of problem solving 
courts into other spheres (as it already has with mental health courts, DWI courts and family 
courts). 
 More experimental design research on drug courts would provide additional 
understanding of how these courts work.  Longitudinal, experimental design inquiries are present 
in the literature, but they (most likely for the sake of practicality) follow one or two jurisdictions 
(Deschenes, Turner, & Greenwood, 1995), (D. C. Gottfredson, Najaka, Kearley, & Rocha, 
2006).  The complications of experimental research with human subjects would certainly apply 
here.  The requirement to insure that all those who want the drug court intervention receive it 
while isolating an adequate control group would present an ethical challenge.  Also, defining the 
demographic and other attributes (drug of choice, criminal record, previous treatment history, 
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etc.) would pose a challenge.  However, this is just the sort of rigorous inquiry that would build 
the credence and viability of drug courts over the long term. 
 Another area of inquiry that should be considered is an examination of drug court staff 
attitudes and the implications of how their interactions affect drug court participants.  An 
instrument such as the Working Alliance Inventory (WAI) has been studied to measure the 
strength of relationships between parolees and parole officers (Green et al., 2013) as well as in 
traditional clinical settings. The WAI is a set of related measures that includes client, therapist, 
and observer-rated versions (Mallinckrodt & Tekie, 2015).  The instrument is administered to 
client and service provider to give a quantitative measure of the impressions of each on the 
therapeutic relationship.  An instrument such as this administered in a drug court setting would 
provide valuable, quantifiable insight into drug court therapeutic relationships that would 
complement qualitative studies nicely.  
 As discussed in Chapter 2, application and development of further theoretical foundation 
for drug courts is warranted.  This more rigorous theoretical approach could address concerns 
that drug courts are simply too different from each other for research in any one drug court to be 
considered program evaluation rather than assessment of a uniformly applied intervention.  
During the course of this project, another study was published linking Life Course Theory and 
drug courts (Messer, Patten, & Candela, 2016).  This author hopes to see additional theory 
development in the form of exploratory and qualitative study in addition to the types of studies 
cited immediately above in the near future.  This sort of theory-based inquiry coupled with 
empirical evidence will open up a new era of veracity and legitimacy for drug courts. 
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Conclusion 
 The proliferation of drug courts throughout the world over the last two decades presents 
an opportunity and a challenge.  The effectiveness of treating rather than punishing drug 
offenders that has emerged in the literature is appealing on its face.  However, more work needs 
to be done to demonstrate their effectiveness and impact for the drug court movement to 
maintain momentum and for the philosophy of treatment to spread to other areas of the justice 
system.  There is much that researchers still do not know and the questions of ‘how’ and ‘why’ 
drug courts work have not been sufficiently addressed.  This research study is an examination of 
secondary data from one drug court to attempt to correlate factors that contribute to success (as 
defined by graduation) in drug court.   
By utilizing a theoretical grounding in Life Course Theory, Social Capital Theory and 
Recovery Capital Theory, the hope is to introduce an additional level of theoretical foundation 
lacking in the current drug court literature.  Results from the study demonstrate low to moderate 
ability to predict drug court graduation using the factors studied.  Among the factors found to 
contribute to program success were participants having children, their employment status, 30-day 
abstinence, age, and race. There is still a large amount of additional inquiry to be done to fully 
understand the impact of drug courts on the well-being of the participants and on the success of 
drug courts as a policy intervention.  
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RICHMOND ADULT DRUG TREATMENT COURT 
INTRODUCTION 
 
Welcome to the Richmond Adult Drug Treatment Court [RADTC] in the Circuit Court of 
the City of Richmond.  This handbook is designed to answer questions, address 
concerns and provide overall information about the Adult Drug Court.  As a participant, 
you will be expected to follow the instructions given by the Circuit Court judge and 
comply with the treatment plan developed for you by the Drug Court team. This 
handbook details what is expected of you as an RADTC participant, and provides 
general program information.  You are encouraged to share this handbook with family, 
friends, and anyone seeking information about the RADTC. 
 
PROGRAM DESCRIPTION 
 
The RADTC is a court-supervised substance abuse intervention and treatment program 
for non-violent felony offenders.  It is a voluntary program that includes regular court 
appearances before the Circuit Court judge presiding over the RADTC. Treatment 
includes drug testing, individual and group counseling, and regular attendance at 
recovery group meetings i.e., 12 step meetings (Narcotics Anonymous or Alcoholics 
Anonymous).  We utilize a team approach with on-site clinicians providing substance 
abuse treatment, and probation officers and case managers coordinating ancillary and 
supervision services.  The program’s length is a minimum of 16 (sixteen) months. 
However, the actual length of time you stay in the program is determined by your 
progress as a Drug Court participant.  Throughout the program, you will be encouraged 
and assisted to: 
 
 Obtain a drug free lifestyle 
 Develop and maintain a productive, law abiding lifestyle 
 Enhance employment skills through vocational training and/or job placement services 
 Increase involvement in the recovery community 
 Identify the warning signs of relapse and engage in relapse prevention planning 
 Identify specific needs for your lifestyle and develop a treatment plan designed to work 
toward recovery 
 
Only defendants convicted of non‐violent offenses, including drug offenses and drug related 
property crimes, are eligible for the program.  
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Defendants with any criminal history of violent offenses (as defined in §17.1‐805 or §19.2‐297.1 
of the Code of Virginia), sex offenses, felony weapons convictions, or with significant mental 
health problems (to the extent they are unable to participate in an outpatient program), are 
ineligible to participate in the program.  Distribution offenses may be eligible at the discretion 
of the Commonwealth Attorney.  The Commonwealth Attorney has the absolute right to a veto, 
denying any defendant entrance or participation in the Adult Drug Court, for any reason ‐ 
stated or unstated. 
 
If you have pending charges in additional jurisdictions, they must be adjudicated prior to 
entering the RADTC. You must live within a 25 mile radius of the RADTC office. 
DRUG COURT SUPERVISION 
 
As a Drug Court participant, you will be required to appear in Drug Court on Fridays at 10:00 
a.m. for status hearings.  The frequency of your status hearings is determined by your overall 
progress in the program.  The Judge will receive a progress report prepared by your substance 
abuse clinician and probation officer or case manager regarding your drug test results, 
attendance and participation in group and individual counseling sessions, as well as 
employment, community service, and any other program requirements.  The goal of the Drug 
Court program is to help you achieve total abstinence from all addictive mood‐altering 
substances, including alcohol.   
 
Failure to appear in court on the date and time you are scheduled could result in a warrant 
being issued for your arrest.  If you cannot appear in court as scheduled, you MUST notify your 
probation officer or case manager and attorney as soon as possible to address why you cannot 
appear. 
 
Warrants and/or new arrests could result in your termination from the Drug Court program.  
Immediately notify your probation officer, clinician, case manager, and your attorney within 
three days of any new arrests.  Other violations which could result in termination include: 
  
 Consistently missing drug tests 
 Demonstrating a lack of motivation by failing to cooperate with the treatment 
program 
 Consistently making false statements 
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 Failing to comply with program requirements 
 Violence or threats of violence directed at treatment staff or other clients 
 
If you have any questions about your court appearances, contact the Drug Court office at (804) 
646‐3655 between the hours of 8:30 a.m. and 5:00 p.m., Monday through Friday or your 
attorney.  For emergency purposes, you will be given the cellular phone numbers of your 
substance abuse clinician and probation officer or case manager. 
 
 
DRUG COURT PROGRAM RULES 
 
As a Drug Court participant, you will be required to abide by the following rules: 
 
 Fraternization while participating in the RADTC is not permitted under any 
circumstances. Fraternization is defined as becoming romantically involved with 
another participant, and this applies to females with males, males with males, 
and females with females. Participants who engage in this behavior will be 
removed from the program. 
 
 Show up to your group sessions on time.  Contact your probation officer or case 
manager, and your clinician if there is a possibility that you may be late. If you 
are late, you will not be allowed to attend group.  Participants who are late must 
take the assignment(s) given, report to an assigned area, complete the 
assignment(s), and talk to the group facilitator after the group session. 
 
 No eating in group. Cigarettes, beverages [including coffee] and food are not 
permitted during group.  Drinking water in bottles, gum and throat lozenges are 
permitted if they are not disruptive.  Bathroom needs should be taken care of 
prior to group meetings. 
 
 You are required to dress appropriately for court and treatment sessions.  Refer 
to the dress code section of this manual for the policy.  Failure to dress 
appropriately can result in a sanction. 
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 You must not behave in a violent manner or threaten other participants or staff. 
Violent or inappropriate behavior will not be tolerated and will be reported to 
the court. Such conduct may result in termination from the program. 
 
 Racial/ethnic slurs and name‐calling will not be tolerated. 
 
 NO STEALING. 
 
 No weapons, alcohol, drugs or drug paraphernalia are permitted in the group 
rooms or on the program grounds.  Work tools may be left with staff during 
group times. Violation of this rule will result in immediate dismissal from the 
program. 
 
 If you report to the program under the influence of alcohol, drugs, or 
prescription drugs that have not been cleared by staff, you will not be permitted 
to attend group and will be directed to report to your probation officer or case 
manager. 
 
 Groups are for business.  Outside distractions such as side talk, personal 
business, daydreaming, and sleeping are not permitted.  You are required to be 
actively involved in the group discussion. If the discussion seems to be dull, the 
participant may present a topic that he/she believes would be more suited for 
group discussion. 
 
 Groups are to be used for self‐examination, not for finding fault or blame. 
 
 Groups are confidential.  Information shared in the group is not to be discussed 
outside the group setting. What is heard during group remains in the group.  A 
breach of the confidentiality policy will result in your termination from the 
program. 
 
 Participants may not bring significant others, friends, family members or children 
to the Drug Court program without prior permission from staff. 
 
 No cell phone use will be permitted in the Drug Court office.  Cell phones must 
be turned off prior to entering the office.  Failure to abide by this rule will result 
in confiscation of the cell phone by a staff member. 
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 Attendance at all treatment sessions is mandatory.  This includes individual and 
group counseling, educational sessions and recovery group [e.g. NA and AA 
meetings] or other meetings essential to your recovery.  If you are unable to 
attend a scheduled session, you must contact the appropriate staff member with 
whom your appointment is scheduled. 
 
 
HOME CONTACTS AND CURFEW CHECKS 
 
Drug Court staff will conduct home contacts at the residences of all Drug Court participants.  
The staff verifies and approves the addresses of all clients assigned to the program. If your 
home address, phone number, or emergency contact information changes while you are a 
participant of the Adult Drug Court Program, it is your responsibility to notify program staff as 
soon as this occurs.  You are to obtain and complete the program’s emergency contact form 
and return it immediately to staff at the program. Failure to notify staff of these changes may 
result in you receiving a sanction.  Staff conducting the home contact may search your home 
and personal property for contraband at any time. They may also verify employment locations. 
The staff’s contacts will include curfew checks. The staff provides a monitoring function for the 
team by reporting on a participant’s activities in the community, and making recommendations 
to other staff members.  This information is presented in the form of progress reports at the 
weekly Drug Court staff meeting 
 
Curfews are as follows: 
 
Evaluation/Probationary Phase      10:00 p.m.  
 
Phase I             11:00 p.m. 
 
Phase II             11:00 p.m. 
 
Phase III             Midnight   
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Graduates/Aftercare        1:00 a.m. 
 
These curfew times are subject to change based on your behavior.  Participants that are in 
treatment, transitional, or recovery housing must abide by the rules of that facility. 
  
If your work schedule conflicts with the required curfew, you must provide your probation 
officer or case manager with a work schedule. After verification of the schedule, your curfew 
hours will be modified accordingly.   
 
 
 
 
COURT FINES AND COMMUNITY SERVICE 
 
As a participant, you have agreed to pay any fines, restitution, and costs imposed by the 
Richmond Circuit Court.  Payments toward court costs shall be made directly to the 
clerk’s office located at: 
John Marshall Courts Building 
 400 North Ninth Street Room 102 
Richmond, Virginia 23219 
 
The community service rate has been set at $15.00 per hour.  As part of your program 
requirements, you must complete a minimum of 45 community service hours prior to 
graduation.  The total of $675.00 will be applied toward your fines and costs in Drug 
Court cases upon completion of the program and removal from probation supervision.  
In cases of financial hardship, you may request the opportunity to perform community 
service for more than the mandated 45 hours.  You must make this and any other 
request of the court through your probation officer or case manager, prior to appearing 
in court for the weekly status hearing. Only the Judge can grant approval for you to 
substitute community service for monetary payments.   
 
You are required to complete 15 hours of community service in Phases I, II and III of the 
program.  You may complete your 45 hours ahead of the required schedule.  You 
should submit your preferred site to your probation officer or case manager.  Once the 
site has been approved, you will be given a form to record your hours.  These forms 
must be submitted to your probation officer or case manager on a regular basis.  Your 
probation officer or case manager will contact the site supervisor periodically to verify 
your hours.  
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Community service will not be substituted for restitution payments. If you are required to 
pay restitution, your probation officer or case manager will establish the payment 
schedule as mandated by the court order. You must retain a receipt for your personal 
records, and a copy of the receipt will be retained in your file by your probation officer or 
case manager. Payments will be reported to the Judge as part of your regular progress 
report. 
 
A case will not be dismissed until restitution obligation(s) has been satisfied 
 
 
DRUG COURT FEES 
 
You are also required, by statute, to pay Drug Court fees. The RADTC fees are $15.00 
per month. These fees must be paid on time in order for you to progress through the 
treatment phases and to graduate from the program. These fees are due by the 15th of 
each month. You must start paying Drug Court fees once you enter the first phase of 
the program and secure employment or another method of income such as disability or 
retirement income. Drug Court fees may be paid in advance and are non- refundable.  If 
you become temporarily unemployed, the fees owed will be reduced to $5.00 per month 
until employment is regained.   
 
Once you secure employment you are obligated to pay Drug Court fees during the 
remainder of your participation in the program.  Payment should be made to the 
designated drug court staff member. Failure to pay fees on a timely basis will be 
reported to the Judge and may also result in more frequent court appearances. Please 
keep your receipt. If you have any questions about the Drug Court fees, please talk with 
the designated staff member. 
 
INTAKE PROCEDURES 
 
The Drug Court office is located in the Public Safety Building, 501 North 9th Street, 2nd Floor, 
Richmond, Virginia, 23219.  Immediately after the court orders you to enter the 
evaluation/probationary phase of Drug Court, or within 48 hours of your release from 
incarceration, you must report to the Drug Court office.  During the first 30 days of participation 
(known as the evaluation/probationary phase), the Drug Court staff will develop a treatment 
plan.  During this time you will attend group sessions, submit urine screens and appear in court 
every Friday at 10:00 a.m.  You must comply with the probationary phase requirements in this 
manual. Acceptance into the Drug Court program will be based on attendance, appropriate 
participation, and motivation for treatment.  At the completion of the evaluation/probationary 
period a recommendation will be sent to the Judge for your sentencing hearing. As a 
probationary period participant, you may be accepted or denied entry into the program after 
the 30‐day evaluation period.  
 103 
 
ASSESSMENT AND TREATMENT PLANS 
 
A substance abuse clinician will administer your drug and alcohol assessment to you. After this 
assessment, you will meet with a clinician to develop your treatment plan.  The plan will 
identify your needs and act as a guide throughout your treatment.  This plan will assist you in 
setting goals, selecting methods for meeting these goals and developing a target date for 
achieving these goals.  The plan will be kept in your treatment file for regular review and 
necessary updates as you progress through the program.  You and your substance abuse 
clinician will discuss any revisions to the plan. 
 
TESTING FOR DRUGS AND ALCOHOL 
 
As a participant (even in the probationary phase), you will be tested throughout the entire 
treatment process.  You may be tested any time while in the Drug Court program, including 
holidays.  As you progress through the program, testing will be required on a less frequent 
basis. In addition to regular drug and alcohol testing, random drug and alcohol testing will be 
conducted on weekends and holidays. You may also be tested during home contacts. The Drug 
Court Judge will have access to all test results, including any failures to test. Your failure or 
refusal to provide a urine sample within a reasonable time period will be considered a 
violation of Drug Court conditions, and reported to the Judge as a positive screen.  The Judge 
may impose consequences that range from sanctions [including incarceration] to termination 
from the program. The goal of the Drug Court is to help you achieve total abstinence from illicit 
or illegal drugs and alcohol. By participating in the Richmond Adult Drug Treatment Court, you 
understand that you are not to use alcohol or illegal drugs.  If you test positive for alcohol or 
drugs your supervision requirements can be increased. 
 
 
The Drug Court program currently uses hand‐held urine tests, breathalyzers, and oral swabs to 
detect for the use of mood altering substances.  With the hand‐held screening tests, a result is 
obtained by dipping the sticks in the sample container.  The results appear within minutes 
indicating a positive or negative result.  If a specimen tests positive, you will be notified 
immediately.  You may dispute the results by a request that the urine sample be sent to the 
independent laboratory for final analysis.  Confirmation of drug testing through a laboratory is 
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$27.00. If results from the laboratory indicate a negative finding, the Drug Court will absorb the 
confirmation cost.  If a positive confirmation is received you will be required to pay $27.00 for 
the laboratory confirmation.  Example: If you test positive and claim to have taken a 
prescription, and if the lab shows a different substance(s) you will be charged for the lab. 
Additionally, you will not only receive the mandatory program sanction, but an additional three 
(3) sanction for being dishonest about your use and the test results.  If a lab fee is owed, you 
may not request another lab test until that fee is paid. 
 
Once the request has been made to send a urine sample to the lab for confirmation and the 
sample has been packaged, you cannot withdraw the request and will be due the additional 
three (3) day sanction if the sample is confirmed as a positive screen by the laboratory. 
 
A positive confirmation is final. The final analysis of the urine sample by the laboratory, and 
results from the breathalyzer, are conclusive. You may not dispute the results from the 
laboratory drug test, breathalyzers, oral swab, or any positive tests obtained at other agencies. 
You waive any right to challenge the results, methodology, or equipment. In the future, the 
Drug Court program may use a machine operated urinalysis test. The machine test result will be 
final. You may not request a laboratory analysis or dispute the results, methodology, or 
equipment. In summary, you may not dispute the results from the laboratory drug test, 
breathalyzer, or machine operated urine test. 
 
All Drug Court participants are given one (1) hour within the testing times listed below to 
provide a sample for analysis. Failure to produce a sample within the allotted time period will 
result in a jail based sanction (if you are not in the probationary phase of the program).  
 
Drug/Alcohol testing times are as follows: 
 
Day           11:30 a.m.–12:30 p.m. 
Evening       5:00 p.m.-6:00 p.m. 
 
Drug Court may honor positive drug testing results from partnering treatment, transitional, or 
recovery facilities. 
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MEDICATIONS 
 
To insure honesty in Drug Court, the following limitations will be placed on over the 
counter medications.  You may NOT take over the counter medications containing ephedrine, 
pseudoephedrine or phenylpropanolamine.  Examples of these medications are Sudafed, 
Nyquil, Contac, Sine‐Off and Allerest.  You may NOT take medications that contain alcohol e.g, 
Nyquil.  This is not a complete list of products containing these ingredients.  You must read the 
package labels or ask the pharmacist for a medication that does not contain alcohol and/or 
these substances. 
 
 
**TO ALLEVIATE ANY PROBLEMS, YOU SHOULD SEEK CLEARANCE AND/OR APPROVAL FROM 
THE SUBSTANCE ABUSE CLINICIAN WHEN TAKING OVER THE COUNTER MEDICATIONS.** 
 
IF YOU ARE PRESCRIBED PRESCRIPTION MEDICATION[S] YOU MUST NOTIFY YOUR CLINICIAN 
AND ADHERE TO THE FOLLOWING: 
 
 
 Inform your doctor of your history of substance abuse and your current 
involvement with the drug court program and current treatment participation. Ask 
your doctor if there are non-narcotic pain medications or alternative forms of 
medical treatment available. 
 
 Have your doctor fill out the drug court medical form that is provided (copy 
attached) Return the completed form to your drug court clinician. If you are 
receiving a prescription for narcotics from an emergency room physician, you 
must follow up with a visit to your primary care doctor within two (2) weeks of 
your emergency room visit. 
 
 Immediately advise the Drug Court Staff of the prescription(s) you have received 
prior to using the medication. 
 
 If directed by the Drug Court staff or judge, you will make your 
prescription available in order to count the number of pills used from the date the 
prescription was filled. The medication must be used as prescribed. 
 
 106 
 Once the prescription has expired or the time all pills should have been used, 
none of the pills should be in the possession of the Drug Court participant. A 
positive drug test after that time because the participant took left over medication 
will result in the participant being sanctioned. If you are given a prescription 
and decide against taking it or do not take the entire amount prescribed, 
follow the instructions of the Drug Court staff as to how to destroy the 
remaining amount of medication 
(See form at back of manual) 
 
 
Should your medical condition require the use of mood altering chemicals, you will be 
given additional treatment assignments and suspended from phase movement until the 
use of medication is completed, unless previously approved by staff. 
 
 
 
MEDICATION ASSISTED THERAPY 
 
As a participant, you understand and agree that in order to receive medication assisted 
treatment, you must agree to be treated and/or monitored by a physician approved by the 
Drug Court staff. 
 
 
TESTING (STATUTE) 
 
The purpose of testing for substances in a drug treatment program is to support your recovery. 
Testing also helps insure honesty in the program. An attempt to cheat on the drug and alcohol 
testing procedure is dishonest and contrary to any treatment goals. As outlined below, it is 
illegal to defeat drug and alcohol screening tests.  
 
Code of Virginia:  
 
18.2-251.4 - Defeating drug and alcohol screening tests; penalty - A. It is unlawful 
for a person to  
1) sell, give away, distribute, transport or market human urine in the 
Commonwealth with the intent of using the urine to defeat a drug or 
alcohol screening test; 
2) attempt to defeat a drug or alcohol screening test by the substitution of a 
sample;  
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3) adulterate a urine or other bodily fluid sample with the intent to defraud a 
drug or alcohol screening test. 
 
 B.  A violation of this section is a Class 1 misdemeanor. (2001, c. 379.) 
 
 
COUNSELING 
 
Substance abuse treatment is comprised of individual, group and educational sessions.  As a 
participant, part of your treatment plan is the required participation in all three levels of 
counseling.   They are designed to develop self‐awareness, realize self‐worth and practice self‐
discipline.  The individual and group counseling sessions will include problem identification and 
alternative solutions.  The education groups will include videos, lectures and question/answer 
sessions.  You must contact your probation officer or case manager and clinician if you are 
unable to attend or will be late for a scheduled session.  Your attendance at counseling sessions 
will be reported to the Judge as part of your progress report.   
 
 
 
TWELVE STEP AND RECOVERY MEETINGS 
 
Attendance is required at 12‐step meetings such as Narcotics and/or Alcoholics Anonymous, or 
other recovery meetings.  Regular attendance at these recovery meetings is mandatory.  These 
fellowships help you see how others with similar problems have recovered from their 
addictions.  You also learn that changing to a drug free lifestyle can be a positive, exciting 
experience. 
 
Very few alcoholics and addicts maintain recovery without this support system.  As a 
participant, when your recovery begins you will see how your experiences can be helpful to 
others in similar situations. You will also have a sense of how being “a part of” instead of “apart 
from” can be rewarding. Addiction is definitely a disease of isolation and the support groups 
put you back in touch with others.   
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Your substance abuse clinician will give you information regarding the times and locations of 
12‐step and other recovery meetings.  Your clinician will also direct you to special interest and 
recovery events in the community. 
 
All participants are required to attend recovery group [e.g., NA/AA] meetings each week as 
required by your treatment plan.  Your clinician will provide you with meeting verification slips.  
These slips must be fully completed, signed appropriately and returned to your clinician every 
Monday.  You will be sanctioned according to the sanction grid in this manual if you fail to turn 
in these meeting slips each week. See your clinician if you are uncertain of the number of 
meetings you are required to attend. 
 
 
TREATMENT PHASES 
 
The RADTC program is a five phase, highly structured, outpatient treatment program that lasts 
a minimum of 16 months. The length of the phases varies depending upon your individual 
progress.  Each phase consists of specified treatment objectives and therapeutic and 
rehabilitative activities.  The components are described below. 
 
 
EVALUATION/PROBATIONARY PERIOD 
Duration:  30 days 
 
During the evaluation/probationary period, you are admitted into the program on a 
provisional basis.  The staff will administer the “Addiction Severity Index” and drug 
screens to assess overall issues, and develop a treatment plan.  The plan will allow you 
to set goals and develop target dates for achieving these goals.  If you are actively 
using drugs, additional focus is placed on stabilizing you and education related to 
addiction and pharmacology will be provided to you.   
 
Inability to maintain abstinence during the probationary phase may indicate a need for an 
inpatient component prior to entering Drug Court. Some examples of a more structured 
program would be residential substance abuse treatment or the Diversion Center.  
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During this probationary period, you must: 
 
 Meet with designated staff weekly, as directed 
 Seek gainful employment or enroll in school/vocational training for a minimum of 12 
credit hours.  If unemployed, you must submit at least three (3) job verification forms to 
the designated staff daily 
 Attend the required number of meetings per week [e.g., twelve steps NA/AA]. 
 Attend twelve (12) group sessions with satisfactory participation; if unemployed, attend 
sixteen (16) sessions 
 Attend a minimum of four (4) unemployment groups, if unemployed 
 Establish a primary and secondary community service site in writing  
 Register and complete paper work to secure a VCC card, ID, social security card, birth 
certificate, and secure a primary care physician 
 Complete the Drug Assessment (ASI), which is required prior to phase movement 
 Submit to drug screens as directed by staff 
 Begin working on relapse prevention plans 
 Complete assignments as instructed 
 
Upon acceptance into the drug court program, you will receive a form to take to the City of 
Richmond Health Department to be tested for HIV/STD’s. You must complete this testing prior 
to entering Phase I. You must also complete all required assessment tools prior to entry into 
Phase I. 
 
PHASE I 
Duration:  17 weeks 
 
Requirements for Phase I are: 
 
 Secure employment or enrollment in school. Failure to obtain employment, or remain 
employed or enrolled in school, will result in daily reporting for group sessions and/or 
community service; 
 Secure a home group and a sponsor; 
 Oral and/or written presentation of an acceptable first step; 
 Attend the required number of recovery group meetings per week [e.g., twelve step 
AA/NA]; 
 Attendance at a minimum of fifty‐one (51) group sessions with satisfactory group 
participation; 
 Meet weekly with designated staff as directed; 
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 Attendance at all scheduled groups and individual sessions, recovery group meetings 
and drug screens (no missed sessions for thirty (30) days prior to phase movement); 
 Submit to drug screens as directed by staff; 
 Participate in recreation and fellowship activities; 
 Appear in court as required; 
 Completion of 15 hours of community service; 
 Make timely payments of Drug Court fee; and 
 Secure a Primary Care Physician [PCP] 
 
Movement to Phase II requires your completion of the above tasks and drug free testing for a 
minimum of sixty (60) days. [Not eligible for phase movement while taking prescribed 
medication unless you are approved by staff]  If you are serving sanctions or incarcerated on 
new offenses you cannot accrue time for phase movement. You will be eligible to move to 
Phase II after ninety (90) days/13 weeks if you: 
 
 Attend all scheduled group sessions with satisfactory participation; 
 Attend all support meetings as scheduled; 
 Submit all negative drug screens; 
 Complete all phase tasks; 
 Remain sanction‐free; 
 Receive the approval of the treatment team; and 
 Complete phase movement form 
 
 
 
 
PHASE II 
Duration:  17 weeks 
 
Requirements for Phase II are: 
 
 Remain employed or in school.  Failure to maintain employment or remain in school will 
result in daily reporting by you for group sessions and/or community service. 
 Become active in a home group. 
 Actively participate in the group sessions, including facilitating a session. 
 Complete a 2nd step workbook and discuss it within the group. 
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 Attend the required number of recovery group meetings per week [e.g., twelve steps 
AA/NA]. 
 Attend at a minimum of thirty‐four (34) group sessions with satisfactory participation. 
 Attend all individual sessions monthly with designated staff. 
 Submit to drug screens as directed by staff. 
 Attend all scheduled group and individual sessions, 12 recovery group [e.g., twelve steps 
AA/NA] meetings and drug screens for thirty (30) days prior to phase movement. 
 Participate in recreation and fellowship activities. 
 Complete fifteen (15) hours of community service. 
 Make timely payments of Drug Court fees. 
 
Movement to Phase III requires your completion of the above tasks and drug free testing for a 
minimum of ninety (90) days.  [Not eligible for phase movement while taking prescribed 
medication unless approved by staff]  You will be eligible to move to Phase III after ninety (90) 
days/13 weeks if you have: 
 
 Attended all scheduled group sessions with satisfactory participation, 
 Attended all support meetings as scheduled, 
 Submitted negative drug screens, 
 Completed phase tasks, 
 Remained sanction free, 
 Received the approval of the treatment team, and 
 Completed phase movement form 
 
 
PHASE III 
Duration:  17 weeks 
 
Requirements for Phase III are: 
 
 Remain employed or in school.  Failure to maintain employment or remain in school will 
result in daily reporting, by you, to group sessions and/or community service 
 Mentor a new participant entering the program 
 Complete fifteen (15) hours of community service 
 Exhibit a leadership role in the group sessions 
 Attend the required number of recovery group meetings per week [e.g., twelve steps 
AA/NA] 
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 Attend a minimum of seventeen (17) group sessions with satisfactory participation 
 Complete of 3rd step workbook and presentation of an acceptable relapse prevention 
plan 
 Submit to drug screens as directed by the staff 
 Attend all scheduled group sessions, one individual session per month, 12 recovery 
group [e.g., twelve step] meetings and drug screens for thirty (30) days prior to 
graduation 
 Attend scheduled monthly meeting of the Drug Court Alumni Association. 
 Make timely payments of Drug Court fees 
 Attend all individual sessions monthly with designated staff. 
 
 
 
Rotation to the Aftercare phase requires completion of the above tasks and drug‐free testing 
for a minimum of 120 days. [Not eligible for phase movement while taking prescribed 
medication unless approved by staff]. You will be eligible to move to Aftercare after ninety (90) 
days / 13 weeks if you have: 
 
 Attended all scheduled group sessions with satisfactory participation 
 Attended all support meetings as scheduled (three times a week) 
 Submitted all negative drug screens 
 Completed all phase tasks 
 Remained sanction free 
 Received approval of the Drug Court staff 
 Complete phase movement form 
 
 
NOTE:  PARTICIPANTS SERVING SANCTIONS OR WHO ARE INCARCERATED ON NEW CHARGES CANNOT 
ACCRUE TIME FOR PHASE MOVEMENT 
 
 
AFTERCARE PHASE 
Duration:  6 months 
 
During this phase, you will partake in Aftercare supervision.  You will continue to meet with 
your probation officer/case manager as instructed so that close supervision may be maintained.  
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You must continue to submit urine screens to ensure compliance and safeguard against relapse.  
You are expected to maintain employment and failure to maintain employment or remain in 
school will result in daily reporting to attend group sessions and/or community service. Strong 
involvement with a home group and sponsor through NA/AA is considered vital to recovery.   
 
 
The requirements for the Aftercare phase are as follows: 
 
 Attend four (4) drug court group sessions each month for the first two months, three (3) 
group session for the next two months, and two (2) for the final two months 
 Attend all individual sessions monthly with designated staff 
 Submit a minimum of three (3) recovery group meeting slips weekly [e.g., NA/AA] 
 Submit drug screens as directed 
 Complete a post‐graduation interview with staff 
 Complete steps four and five 
 
As an Aftercare participant, you are expected to be involved in the Adult Drug Court Alumni 
Association. The Association meets biweekly and was organized to help participants who have 
completed the treatment requirements of the program in continuing their personal battle 
against drug addiction.  This group gives you an opportunity to give and receive support from 
others as you all continue to work towards maintaining sobriety.  Participation in this group is 
mandatory for Phase III and Aftercare participants.  Alumni members will provide prospective 
and recent graduates with information as well as act as role models and mentors to participants 
in drug court.   
 
It is rewarding for graduates to assist others who are on the same path they have already taken.  
In addition, helping others is a reminder of what life was like on drugs. You will hear 
suggestions on ways to improve your life while continuing to work on maintaining a balanced 
healthy lifestyle. You will discuss various issues at meetings and speakers on the topics of 
employment, money management, health, relationships and other relevant issues will be 
addressing the group[s]. 
 
At the end of six (6) months, the Drug Court team will review your overall adjustment and 
recommend successful termination / completion, or continuation of the case on supervision by 
the Drug Court. The disposition of your case upon successful termination depends on the terms 
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of your entry into the program. If you are on supervised probation or pre‐trial supervision, you 
are still under supervision until you receive a Circuit Court order releasing you from supervision. 
 
 
GRADUATION CRITERIA 
 
 Achieve a minimum of 180 continuous, sober/clean days, not including any in‐patient 
treatment time 
 Complete a minimum of 119 scheduled group sessions 
 Complete required recovery group or 12 step meetings (3 meetings per week) 
 Complete all classwork and homework assignments 
 Maintain and use a recovery group, 12 ‐ step sponsor, and home group 
 Remain crime free 
 Pay all Drug Court fees 
 Participate in a pre‐graduation interview with staff 
 
The Drug Court team must be satisfied that you made significant life changes and appear, from 
all available evidence, to be engaged in a stable recovery process. 
 
Once you successfully complete the Aftercare phase, you will be eligible for completion of the 
program.  The Drug Court team will provide a recommendation to the Judge who will make the 
final determination for discharge from supervision.  There is a formal graduation, usually twice 
a year.  At this graduation, families and friends will be invited to join you and the other 
graduates as the RADTC team congratulates you for successfully completing Drug Court and 
achieving the goal of establishing a drug free lifestyle.  It is anticipated that following 
graduation, you will become a member of the Drug Court Alumni Association. You will be 
expected to provide insight and honest answers to others who are struggling to stay clean and 
achieve a balance in their lives. 
 
 
 
SANCTIONS 
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Violations of treatment rules and supervision requirements will be dealt with through the 
use of graduated sanctions.  If you do not maintain contact with the probation 
officer/case manager, substance abuse clinician, or do not follow program rules, you 
may be given sanctions.   
 
Sanctions range from presenting a paper at a group meeting or a court hearing, 
performing community service hours, to incarceration or termination from the program. 
Sanctions can also include increased court appearances or appointments with the 
clinician or probation officer/case manager, increased frequency of drug/alcohol testing, 
increased treatment or recovery group [e.g., NA/AA] attendance, changed curfews, 
inpatient treatment or referral to a Department of Corrections special program such as 
the Detention or Diversion Center. Unsuccessful termination or withdrawal from the 
program will result in a scheduled hearing before the Drug Court Judge. 
 
If you test positive or miss a urine screen you will also have your treatment plan modified as 
noted below: 
 
Phase I – no change but extra recovery group or 12 step meetings may be required 
 
Phase II – report 3 times a week for 60 days 
 
Phase III – report 3 times a week for 60 days – then 2 times a week for the next 30 days   
 
Aftercare – report 3 times a week for 60 days – then 2 times a week for the next 30 days – then 
1 time a week for the next 30 days – then return to modified aftercare reporting status 
 
If, as a Drug Court participant, you are convicted of any misdemeanor (any offense with a 
penalty of 12 months incarceration or less, and / or a fine of $2,500 or less), and the offense 
occurred while you were in Drug Court, you will be returned to the beginning of Phase I. Other 
sanctions may also be imposed, as deemed appropriate by the Drug Court team [e.g., a 
misdemeanor assault conviction may result in termination from the program].  
 
A conviction of two misdemeanors or one felony shall result in termination from the program. 
Based on your conditions of entry, either a sentencing or a probation revocation hearing will be 
scheduled.  You will be returned to your home Judge for a sentencing hearing or one of the 
Drug Court Judges will preside over the probation revocation hearing.  
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During the first 30 days of your participation in Drug Court, as a probationary phase participant, 
you will receive sanctions and/or additional requirements for positive urine screens.  However, 
these sanctions will not be jail sanctions.  Other sanctions that will help you obtain abstinence 
from drug use may be imposed at the discretion of the Drug Court team.   
 
The following range of sanctions applies after you have been in Drug Court for 30 days or if your 
probationary period has been reduced by the Judge to a period of less than 30 days.  The Drug 
Court Judge may vary from the guidelines and the sanction grid when appropriate to the 
individual situation.   
 
If you voluntarily admit to using alcohol or other drugs, but the use cannot be detected through 
testing, you will not be sanctioned. 
 
Blatant or willful disregard for program rules may result in multiple sanctions or an 
increase in sanctions.  Violations could result in sanctions or unsuccessful termination 
from the program.  Examples of such violations include but are not limited to: 
 
 Forging or altering recovery group [e.g. NA/AA] meeting slips 
 Operating a motor vehicle with a suspended or revoked license 
 Possessing, delivering or selling illegal drugs on Drug Court property 
 Adulterating  urine screens  
 Questioning the integrity of Drug Court staff 
 Failing to complete court ordered sanctions 
 Sleeping during group sessions 
 Behaving inappropriately 
 Providing false information about employment 
 Forging job search verification forms 
 Making false statements to Drug Court staff or the Judge 
 Engaging in conduct detrimental to the health, welfare, and public safety of staff and other 
participants 
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**RICHMOND ADULT DRUG COURT SANCTION GRID** 
 
 
 
ACTION 
 
1ST INCIDENT 
 
2ND INCIDENT 
 
3RD INCIDENT 
 
4TH + INCIDENT 
 
MISSED 12 STEP / 
RECOVERY 
MEETINGS 
 
 
 
 
8 hours of 
community 
service.  
Meetings must be 
current by the 
next week  
 
 
16 hours of 
community 
service 
No credit for 
group until 
meetings are 
current 
 
2 days in jail  
 
 
No credit for 
group until 
meetings are 
current 
 
5 days in jail + 
restart current 
phase  
  
Meet with 
treatment team 
 
FORGED 
/ALTERED DRUG 
COURT 
DOCUMENTS 
 
 3 days in jail for 
each forged 
document 
 
Revocation from 
the program and 
CA will 
recommend 
active 
incarceration 
   
 118 
 
DRUG/ALCOHOL 
TESTING AND 
TAMPERING 
   
 Late, Missed 
Screens, Unable to 
give, Adulterated, 
Diluted screens  
 
Each participant is 
responsible for 
submitting a 
sample that is 
able to be tested.  
Dilute screens will 
be considered 
positive. 
 
5 days in Jail 
5 additional days in 
jail will be received if 
the participant tests 
positive for the 
entire week 
Possible referral for 
Detox/Inpatient/ or 
STEP UP & OUT 
 
 
7 Days in Jail 
5 additional days in 
jail will be received if 
the participant tests 
positive for the 
entire week 
Possible referral for 
Detox/Inpatient/ or 
STEP UP & OUT 
 
 
10 days in Jail 
5 additional days in 
jail will be received 
if the participant 
tests positive for 
the entire week 
Possible referral for 
Detox/Inpatient/ or 
STEP UP & OUT 
 
 
15 days in jail 
Possible referral for 
Detox/Inpatient/ or 
STEP UP & OUT 
 
 
5th INCIDENT 
Minimum of  
20 days, STEP UP 
& OUT,  
or 
Revocation from 
the program.  CA 
will recommend 
active 
incarceration. 
 
 
** Treatment plan may be adjusted at any point** 
 
The Judge may vary from the guidelines and the sanction grid when appropriate to the 
individual situation 
 
 
 
 
ACTION 
 
1ST INCIDENT 
 
2ND INCIDENT 
 
3RD INCIDENT 
 
4TH + INCIDENT 
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MISSED 
GROUP & 
INDIVIDUAL 
TREATMENT 
SESSION 
Excused missed 
sessions will be made up 
 
 
8 hrs.  In‐ House 
Community Service 
 
Missed session will 
be made up within 
a week 
 
 
3 days in jail +written 
or oral presentation 
 
Missed sessions will 
be made up within a 
week 
 
5 days in jail 
 
 
 
Missed sessions will 
be made up within a 
week. 
 
 
Revocation from the 
program.  CA will 
recommend active 
incarceration 
 
MISSING JOB 
SEARCH FORMS 
 
4 hours of 
community 
service 
 
8 hours of 
community 
service 
 
2 days in jail 
 
5 days in jail 
FAILURE TO SUBMIT 
THE REQUIRED 
HOURS FOR 
EMPLOYMENT, 
EDUCATION, 
AND/OR 
COMMUNITY 
SERVICE 
 
3 days in jail 
 
6 days in jail 
 
Meet with 
treatment/ 
probation team 
 
9 days in jail 
 
Meet with 
treatment/ 
probation team 
 
Revocation from the 
program.  CA will 
recommend active 
incarceration 
 
CURFEW VIOLATION 
 
Indefinite 8p 
Curfew 
 
**2 days in jail 
if out the entire 
night 
 
3 days in jail + 
Indefinite 8p 
Curfew 
 
 
5 days in jail + 
Indefinite 8p 
Curfew 
 
 
 
 
Revocation from the 
program.  CA will 
recommend active 
incarceration 
 
PROVIDING 
FALSE 
INFORMATION TO 
 
3 days in jail  
 
5 days in jail  
 
10 days in jail 
 
Revocation from 
the program.  CA 
will recommend 
 120 
STAFF ABOUT 
MATERIAL FACTS 
e. g., residence, 
employment 
active 
incarceration 
LATE TO COURT 
 
SANCTIONED AT THE DISCRETION OF THE JUDGE 
 
 
The Judge may vary from the guidelines and the sanction grid when appropriate to the 
individual situation 
 
 
 
 
INCENTIVES 
 
The court applies appropriate incentives to match your treatment progress.  Compliance with 
program rules will result in recognition from the Judge, the Drug Court team members, and 
Drug Court participants. Incentives include certificates, increased travel privileges, decreased 
Court appearances, accelerated phase movement, and gift cards.  
 
 
PARTICIPANT GRIEVANCE PROCEDURE 
 
 
The following procedure is available to you if you wish to seek review of any conflict existing 
between you and a member of the Drug Court staff.  The only disputes to which these 
procedures shall not apply are those that might result in your suspension or dismissal from the 
program. (See Drug Court Program Rules and Sanctions) 
 
If you have a grievance, you must first make an effort to resolve the conflict with the staff 
member(s) in question. 
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If you have discussed the matter with the staff member(s), but remain unsatisfied with the 
resolution of the conflict, you may request the involvement of the Drug Court Coordinator. 
 
After being notified of the complaint, the Drug Court Coordinator will meet with you to hear 
any information regarding the conflict.  All parties involved in the conflict will be questioned 
and given the opportunity to present their respective arguments.  After all evidence has been 
heard, the Coordinator shall render a decision.  You will receive this decision either orally or in 
writing.  
 
COURTROOM ETIQUETTE 
 
 No cell phones or pagers are permitted in the courthouse 
 Sit quietly in the courtroom when court is in session.  The court stenographer is 
recording the proceedings and noise may interfere with the accuracy of what is being 
recorded 
 When addressing the Judge, sit/stand upright and address the Judge as “Judge Jenkins” 
or “Judge Marchant” or “Your Honor”.  Responses of “yes” or “no” are appropriate.  
Refrain from using slang 
 No food, drink or gum chewing is allowed in the courtroom 
 Smoking is prohibited in all government buildings.  When you are free to leave the 
courtroom, designated smoking areas are available outside the building 
 Avoid bringing small children to court.  If you must bring any children, monitor their 
behavior. You may be asked to leave the courtroom if your children become disruptive 
 Appropriate attire is required in Court (see the Dress Code below). Please wear suitable 
clothing. If you require assistance in obtaining appropriate clothing, please notify any 
staff member 
 
 
 
DRESS CODE 
 
Although there are different styles of dress and different ideas of what is appropriate or 
not appropriate the following dress code will be followed for court appearances and when 
reporting to the Drug Court office. If you are unable to obtain suitable clothing, please 
notify any Drug Court staff member. 
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MEN’S DRESS CODE 
 
Acceptable: 
 
 Work attire or religious attire (uniforms, etc.) 
 Collared shirts and long pants. Shirts designed to be tucked in must be completely 
tucked in pants at all times. Pants must be worn around the waist secured by a belt at all 
times (no “Sagging”) 
 Sweaters  
 Knit shirts 
 Clean shoes or sneakers 
 Suits and ties 
 
Prohibited: 
 
 No athletic wear is allowed in Court.  The following is deemed athletic wear: 
o Jerseys 
o Sweat Pants 
o White‐Tees 
o Hats and “Du” rags 
o Shorts 
 No Sunglasses 
 No hats are to be worn in court 
 
 
Failure to abide by this dress code when appearing in court may result in your receiving four (4) 
community service hours as a sanction. Failure to abide by this dress code when appearing in 
the Drug Court office may result in an appropriate sanction by the probation officer/case 
manager. Staff will ask you to leave the office or change your clothes if they see you wearing 
inappropriate clothing.  
 
 
WOMEN’S DRESS CODE 
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Acceptable: 
 
 Work attire or religious attire (uniforms, etc.) 
 Collared shirts and long pants. Shirts or blouses designed to be tucked in must be 
completely tucked in pants or skirts at all times. Pants must be worn around the waist 
secured by a belt at all times, no “Sagging” 
 Sweaters 
 Knit shirts 
 Shoes or sneakers 
 Dresses and skirts, knee length or longer. Slips or linings must be worn with all dresses 
or skirts 
 Modest attire, that is neither form fitting, nor revealing 
 
 
Prohibited: 
 
 No athletic wear is allowed in Court.  The following is deemed as athletic wear. 
o Jerseys 
o Sweat pants 
o White‐Tees 
o Hats and “Du” rags 
o Shorts 
 Tank tops, halters, midriff tops, tube tops, transparent tops, and bathing suit tops  
 Hats and/or sunglasses are not to be worn in group or court 
 Upper and lower portions of the body are to be covered at all times.  Short shorts are 
not permitted at any time.  Shorts of an appropriate length may be worn to the drug 
court office only, and are not to be worn to court. 
 No flip flops 
 No Leggings 
 Appropriate undergarments must be worn at all times 
 
 
Failure to abide by this dress code when appearing in court may result in your receiving four (4) 
community service hours as a sanction. Failure to abide by this dress code when appearing in 
the Drug Court office may result in an appropriate sanction by the probation officer/case 
manager. Staff will ask you to leave the office or change your clothes if they see you wearing 
inappropriate clothing.  
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EMERGENCY CONTACT PROCEDURES 
 
The Drug Court staff is available for emergency supervision needs.  You are not 
expected to abuse this service.  Routine business is conducted during normal office 
hours.  The Drug Court staff members and their families should not be disturbed at 
home except in the case of emergencies. Examples of emergencies in which you 
should contact your substance abuse clinician or probation officer/case manager 
outside of regular office hours are emergency travel in the event of death, medical or 
mental health crises.  You are also encouraged to contact your probation officer/case 
manager if you are arrested for any offense outside of the normal working hours.  Do 
not contact staff to arrange last minute travel. A lack of planning on your part does 
not constitute an emergency.  Those individuals who abuse this service will be 
issued a sanction. 
 
 
 
 
CONFIDENTIALITY 
 
 
Federal and state laws afford confidentiality protection to participants in substance abuse 
programs.  State licensing requires that your identity and privacy be protected.  In response to 
these regulations, the Adult Drug Court developed policies and procedures that guard your 
confidentiality.  You will be asked to sign a statement agreeing that appropriate information be 
shared among the Adult Drug Court team members.  This statement ‐ the CONSENT FOR 
DISCLOSURE OF CONFIDENTIAL SUBSTANCE ABUSE TREATMENT INFORMATION ‐ is included in 
this Manual.  You must sign this form if you want to participate in the Adult Drug Court. 
Although statistical information may be gathered and used for research and evaluation 
purposes, the Adult Drug Court will safeguard your identity.  When you complete the program 
(or if you should be terminated from the program) your Drug Court program file will be sealed.  
However, Circuit Court proceedings and court files [which will not include confidential 
information about your treatment] are open to the public, unless the Circuit Court orders 
otherwise. 
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CONCLUSION 
 
 
The Drug Court program has been developed to help you achieve total abstinence from 
illicit and illegal drugs and alcohol.  The program is designed to promote self-sufficiency 
and to return you to the community as a productive and responsible citizen.  The 
program is voluntary and is your personal choice.  The Judge and Drug Court staff 
members are present to guide and assist you, but the final responsibility is yours.  You 
must be motivated to make this change and commit to a drug free lifestyle.   
 
 
 
GOOD LUCK TO YOU!!!! 
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RICHMOND ADULT DRUG COURT TREATMENT SCHEDULE 
Effective April 1, 2016 
 
MONDAY 
Aftercare group is held on the first and third Monday of the month 
    
9 am. to 9:45 am  Orientation  Mr. Morris 
10 am to 11:30 am  Caseload Process  Ms. Walker 
10 am to 11:30 am  Caseload Process  Ms. Fisher 
10 am to 11:30 am  Caseload Process  Mr. Hanrahan 
10 am to 11:30 am  **Aftercare  Mrs. Epps‐Crawford 
    
5:30 pm to 5:45pm  Orientation  Mrs. Epps‐Crawford 
6 pm to 7:30 pm  Caseload Process  Ms. Walker 
6 pm to 7:30 pm  Caseload Process  Ms. Fisher 
6 pm to 7:30 pm  Caseload Process  Mr. Hanrahan 
6 pm to 7:30 pm  **Aftercare  Mrs. Epps‐Crawford 
TUESDAY 
    
9 am. to 9:45 am  Orientation  Ms. Fisher 
10 am to 11:30 am  Dual Dx Education  Ms. Alexander 
10 am to 11:30 am  Relapse Prevention  Ms. Pitchford 
    
5:15 pm to 5:45pm  Orientation  Mrs. Epps‐Crawford 
6 pm to 7:30 pm  Relapse Prevention  Ms .Fisher 
6 pm to 7:30 pm  Dual Dx Education  Ms. Walker 
WEDNESDAY 
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9 am. to 10:30 am  Vocational Education  Mr. Morris/Ms. Harris 
THURSDAY 
    
9 am. to 9:45 am  Orientation  Mrs. Epps‐Crawford 
10 am to 11:30 am  Women's Issues  Ms. Fisher 
10 am to 11:30 am  Men's Issues  Mr. Hanrahan 
10 am to 11:30 am  Living Skills  Mrs. Epps‐Crawford 
    
6 pm to 7:30 pm  Living Skills  Mrs. Epps‐Crawford 
6 pm to 7:30 pm  Women's Issues  Ms. Walker 
6 pm to 7:30 pm  Men's Issues  Mr. Hanrahan 
    
Please ask any staff member for the holiday information sheet. This sheet will be 
posted in the Drug Court staff office. YOU ARE REQUIRED TO FOLLOW THE HOLIDAY 
REPORTING SCHEDULE.  If you have any questions about a schedule change, please ask 
a staff member.  
 
 
 
 
 
 
 
RICHMOND ADULT DRUG TREATMENT COURT 
CONSENT FOR DISCLOSURE OF CONFIDENTIAL 
SUBSTANCE ABUSE TREATMENT INFORMATION: 
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I_______________________________________, hereby consent to communication between 
the Richmond Adult Drug Treatment Court and the Judge., [or their designated substitutes], the 
Richmond Commonwealth Attorney’s Office (prosecutor), the Richmond Public Defender’s 
Office (defense attorney) or my defense attorney, and the Richmond Adult Drug Treatment 
Court Staff about my substance abuse and my treatment. Richmond Drug Treatment Court 
hearings are recorded and are a matter of public record.  An official, authorized by the Judge, 
may gather statistical information to be used for a Statewide Research and Evaluation Program. 
 
The purpose of and need for this disclosure is to inform the court and other above‐named 
parties of my eligibility and/or acceptability for substance abuse services and my treatment 
attendance, prognosis, compliance, and progress in accordance with the Richmond Drug 
Treatment Court monitoring criteria.  
 
Disclosure of this confidential information may be made only as necessary for and pertinent to 
hearings and/or reports concerning the following:  
 
Indictment/Docket Number(s) and Charges: ___________________________  
_____________________________________________________________ 
    
I understand that this consent will remain in effect and cannot be revoked by me until there has 
been a formal and effective termination of my involvement with the Richmond Adult Drug 
Treatment Court for the case(s) names above, such as the discontinuation of all court and/or, 
where relevant, probation supervision upon my successful completion of the Richmond Adult 
Drug Treatment Court requirements or upon sentencing for violating the terms of my drug 
treatment court involvement and/or, where relevant, supervised probation.  
 
I understand that any disclosure made is bound by Part 2 of Title 42 of the Code of 
Federal Regulations, which governs the confidentiality of substance abuse client 
records, and that recipients of this information may re-disclose it only in connection with 
their official duties.  
 
 
Participant: _____________________________  Date: ___________________ 
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PARTICIPANT CONTRACT 
RICHMOND ADULT DRUG TREATMENT COURT 
 
I have voluntarily chosen to complete treatment in the Richmond Circuit Court’s Adult Drug 
Treatment Court, and I agree to abide by the guidelines and rules in the Participant Manual and 
to abide by the following rules: 
 
I will keep the peace and be of good behavior, and not violate any municipal, county, state, or 
federal laws. I will immediately report any arrests or citations to my probation officer or my 
case manager, and to my attorney.  
 
I understand I must attend all scheduled sessions and appointments made by the staff. If it is 
necessary to miss any sessions, I will notify my probation officer or case manager and bring 
documentation, typed on their letterhead, from my employer or doctor for verification. If I fail 
to call and bring verification to my next scheduled session, it will be considered an unexcused 
absence. Each absence, whether excused or not, will be included in the status report sent to the 
judge.  
 
I understand I will be required to submit to drug and alcohol tests and screens, including 
monitored urine screens. If I am found to be drinking, or fail to produce a urine specimen that is 
sufficient for testing, it will be considered a stall on my part and it will be treated as if it was 
positive for alcohol/drugs. If I am found to be using at anytime during treatment, I agree to 
follow through with referral to detox/inpatient or any recommendation by the treatment staff.  
If sent to detox or inpatient, I agree to return to the program to check‐in with staff to reassess 
my level of participation in the program.  
 
I understand that part of my program includes attendance of required weekly recovery group 
meetings [AA/NA or other recovery group meetings].  I am to bring verification of my 
attendance to my clinician as scheduled on Monday of each week.  If I fail to submit the 
required attendance verification I will be issued a sanction.  
 
I understand I am required to inform staff of any over‐the‐counter medications I may be using 
and that the medications must be non‐addictive and not contain alcohol.   I am also responsible 
for confirming with a pharmacy or medical professional that these medications are non‐
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addictive and do not contain alcohol.   I understand that using mood‐altering medications, 
whether prescribed or not, could exclude me from participation in the program. I understand I 
am also responsible for providing documentation of all prescription medicines I am taking. I am 
also responsible for notifying the staff if there are any changes to the prescriptions.    
 
I understand that if I am found to be under the influence of drugs or alcohol when I arrive for a 
treatment session, I will not be allowed to stay and participate. I agree to surrender my keys to 
my vehicle to the staff for my safety as well as others. I will call someone who is not under the 
influence to drive me home. I understand that if I insist on driving, the staff will be obligated to 
notify the police department of an impaired driver on the road and give a description of the 
vehicle to the police. 
 
I will not travel outside of the Richmond, Henrico, Chesterfield, and Hanover areas without first 
receiving permission from the Drug Court Staff.  
 
I understand I am to cooperate with the treatment staff in formulating my treatment plan. I 
agree to sign the consent forms for the release of information in order to help the staff 
communicate with individuals or agencies that can assist me in my recovery. I understand that 
my failure to comply with the program, including the requirements and guidelines in the 
Participant Manual, can result in additional conditions and requirements that will be made part 
of my treatment plan, sanctions, or termination from the program. 
 
 
I HAVE READ AND UNDERSTAND THE CONTRACT AND ACKNOWLEDGE RECEIPT OF THE 
RICHMOND ADULT DRUG TREATMENT COURT PARTICIPANT MANUAL.  I AGREE TO FOLLOW 
THESE REGULATIONS AND COMPLY WITH REQUIREMENTS IN THIS MANUAL. 
 
 
 
Participant: ____________________________    Date: ______________ 
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Witness: _____________________                              Date: ______________ 
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Dear Medical Professional: 
 
____________________________    is a participant in the Richmond Adult Drug Treatment Court 
Program.  Upon entering the program they agreed to discontinue the use of all mood-altering substances, 
whether illicit, prescribed, or over-the-counter. Such substances include, but are not limited to narcotics, 
tranquilizers, sedatives, muscle relaxants, stimulants, opiates, opiate-based medications, 
benzodiazepines, herbal supplements, alcohol or alcohol-based products, hallucinogens, amphetamines, 
cocaine, or any substance that would interfere with their sobriety or the accuracy of a drug screen. 
This program requires strict adherence to avoiding and abstaining from illegal substances, as well as 
those that have the propensity to be abused, including narcotic painkillers.  Any use of physician 
prescribed, or over the counter medication is not recommended without the knowledge and consent of 
the Drug Court staff who provide monitoring and supervision of the participants.  This participant has 
also agreed to present this letter to their medical provider verifying disclosure that they are currently in 
treatment for a substance abuse disorder, and will provide the name and contact number of the 
prescribing doctor. They also agree not to use mood-altering medication except when the doctor or 
dentist has stated that no other pain relief medication would be appropriate.   
 
The Drug Court staff appreciates your attentiveness to these restrictions as you provide medical or 
dental treatment to this patient.  If you have any questions, please contact our office by telephone at 
(804) 646-3655, or email at gloria.jones@richmondgov.com to discuss any issues relating to this patient 
and treatment at the Adult Drug Court.  Thank you again for your support in our efforts.   
 
Sincerely, 
 
 
Gloria A. Jones, Coordinator 
Richmond Adult Drug Treatment Court Program. 
 
Acknowledgement of Receipt by Medical Professional: 
 
Medical Professional: ___________________________________ 
 
Phone: _______________________________________________ 
 
Prescribed Medication: __________________________________ 
                          __________________________________ 
 
Date: ___________________________________________ 
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THE RICHMOND ADULT DRUG TREATMENT COURT 
CONTACT LIST 
 
Address:  Public Safety Building, 501 North 9th Street, 2nd Floor 
Richmond, Virginia 23219 
 
Hours of Operation: Mon., Tues., and Thurs., 8:30am until 7:30pm 
 
Wed., and Fri., 8:30am until 5:00pm 
 
 
CLARENCE N. JENKINS, JR., JUDGE                                 646‐3815 Office Phone 
 
W. REILLY MARCHANT, JUDGE          646‐6516 Office Phone 
 
GLORIA JONES, COORDINATOR                646‐3756 Office Phone 
 
TANISHA MOSELEY, ADMIN. ASSISTANT                646‐3655 Office Phone 
 
DARTICSHA STEPHENS, PROBATION OFFICER     646‐0024 Office Phone 
 
JENNIFER WALKER, CLINICAL SUPERVISOR     646‐5378 Office Phone 
 
MIKE HANRAHAN, CLINICIAN         646‐3835 Office Phone 
 
GEORGI FISHER, CLINICIAN                                     646‐5294 Office Phone 
   
SONYA EPPS‐CRAWFORD, AFTERCARE MANAGER      646‐5755 Office Phone 
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PAMELA HARRIS, CASE MANAGER       646‐5375 Office Phone 
 
STANLEY MORRIS, STEP UP AND OUT                             646‐3836 Office Phone 
 
SHELIA HOLMES, ASST. COMM. ATTY                 646‐3500 Office Phone 
 
KATHERINE GROOVER, ASST. COMM. ATTY     646‐3500 Office Phone 
 
TINA CASHMAN, SENTENCING ADVOCATE                     225‐4330 Office Phone 
Public Defender Office 
 
SARA GABORIK, ATTORNEY                                              780‐3080 Office Phone 
 
DEVIKA DAVIS, ATTORNEY    780‐3080 Office Phone 
 
JOAN BURROUGHS, ATTORNEY    780‐3080 Office Phone 
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Appendix 2:  The GPRA Instrument
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Form Approved 
OMB No. 0930‐0208 
Expiration Date 03/31/2019 
CSAT GPRA Client Outcome 
Measures for Discretionary 
Programs 
(Revised 06/01/2012) 
Public reporting burden for this collection of information is estimated to average 30 
minutes per response, including the time for reviewing instructions, searching existing 
data sources, gathering and maintaining the data needed, and completing and 
reviewing the collection of information, if all items are asked of a client/participant; to the 
extent that providers already obtain much of this information as part of their ongoing 
client/participant intake or follow-up, less time will be required. Send comments 
regarding this burden estimate or any other aspect of this collection of information to 
SAMHSA Reports Clearance Officer, Room 7-1044, 1 Choke Cherry Road, Rockville, 
MD 20857. An agency may not conduct or sponsor, and a person is not required to 
respond to a collection of information unless it displays a currently valid OMB control 
number. The control number for this project is 0930-0208. 
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A. Record Management 
Client ID
 |____|____|____|____|____|____|____|____|____|____|____|____|____|____|__
__| 
Client Type: 
 Treatment client 
 Client in recovery 
Contract/Grant ID |____|____|____|____|____|____|____|____|____|____| 
Interview Type [CIRCLE ONLY ONE TYPE.] 
Intake [GO TO INTERVIEW DATE.] 
6-month follow-up → → → Did you conduct a follow-up interview?  Yes  No  
[IF NO, GO DIRECTLY TO SECTION I.] 
3-month follow-up [ADOLESCENT PORTFOLIO ONLY] →   
Did you conduct a follow-up interview?  Yes  No 
[IF NO, GO DIRECTLY TO SECTION I.] 
Discharge → → → Did you conduct a discharge interview?  Yes  No 
[IF NO, GO DIRECTLY TO SECTION J.] 
Interview Date |____|____| / |____|____| / |____|____|____|____| 
  Month Day Year 
[FOLLOW-UP AND DISCHARGE INTERVIEWS: SKIP TO SECTION B.] 
1. Was the client screened by your program for co-occurring mental health and substance use 
disorders? 
 YES 
 NO [SKIP 1a.] 
1a. [IF YES] Did the client screen positive for co-occurring mental health and substance 
use  
disorders? 
 YES 
 NO 
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[SBIRT CONTINUE. ALL OTHERS GO TO SECTION A “PLANNED SERVICES.”] 
THIS SECTION FOR SBIRT GRANTS ONLY [ITEMS 2, 2a, & 3 - REPORTED ONLY AT 
INTAKE/BASELINE]. 
2. How did the client screen for your SBIRT? 
 NEGATIVE 
 POSITIVE 
2a. What was his/her screening score? AUDIT = |____|____| 
CAGE = |____|____| 
DAST = |____|____| 
DAST-10 = |____|____| 
NIAAA Guide = |____|____| 
ASSIST/Alcohol Subscore = |____|____| 
Other (Specify) = |____|____| 
______________________________________ 
______________________________________ 
______________________________________ 
3. Was he/she willing to continue his/her participation in the SBIRT program? 
 YES 
 NO 
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A. Record Management - Planned Services [Reported by program staff about client only 
at intake/baseline.] 
Identify the services you plan to provide to the client during 
the client’s course of treatment/recovery. [CIRCLE “Y” FOR 
YES OR “N” FOR NO FOR EACH ONE.] 
Modality Yes No 
[SELECT AT LEAST ONE MODALITY.] 
1. Case Management Y N 
2. Day Treatment Y N 
3. Inpatient/Hospital (Other Than Detox) Y N 
4. Outpatient Y N 
5. Outreach Y N 
6. Intensive Outpatient Y N 
7. Methadone Y N 
8. Residential/Rehabilitation Y N 
9. Detoxification (Select Only One) 
A. Hospital Inpatient Y N 
B. Free Standing Residential Y N 
C. Ambulatory Detoxification Y N 
10. After Care Y N 
11. Recovery Support Y N 
12. Other (Specify) ____________________  Y N 
[SELECT AT LEAST ONE SERVICE.] 
Treatment Services Yes No 
[SBIRT GRANTS: YOU MUST CIRCLE “Y” FOR AT 
LEAST ONE OF THE TREATMENT SERVICES 
NUMBERED 1 THROUGH 4.] 
1. Screening Y N 
2. Brief Intervention Y N 
3. Brief Treatment Y N 
4. Referral to Treatment Y N 
5. Assessment Y N 
6. Treatment/Recovery Planning Y N 
7. Individual Counseling Y N 
8. Group Counseling Y N 
9. Family/Marriage Counseling Y N 
10. Co-Occurring Treatment/ 
Recovery Services Y N 
11. Pharmacological Interventions Y N 
12. HIV/AIDS Counseling Y N 
13. Other Clinical Services  
(Specify) _________________________  Y N 
Case Management Services Yes No 
1. Family Services (Including Marriage 
Education, Parenting, Child Development 
Services) Y N 
2. Child Care Y N 
3. Employment Service 
A. Pre-Employment Y N 
B. Employment Coaching Y N 
4. Individual Services Coordination Y N 
5. Transportation Y N 
6. HIV/AIDS Service Y N 
7. Supportive Transitional Drug-Free Housing 
Services Y N 
8. Other Case Management Services 
(Specify) _________________________  Y N 
Medical Services Yes No 
1. Medical Care Y N 
2. Alcohol/Drug Testing Y N 
3. HIV/AIDS Medical Support & Testing Y N 
4. Other Medical Services 
(Specify) _________________________  Y N 
After Care Services Yes No 
1. Continuing Care Y N 
2. Relapse Prevention Y N 
3. Recovery Coaching Y N 
4. Self-Help and Support Groups Y N 
5. Spiritual Support Y N 
6. Other After Care Services 
(Specify) _________________________  Y N 
Education Services Yes No 
1. Substance Abuse Education Y N 
2. HIV/AIDS Education Y N 
3. Other Education Services 
(Specify) _________________________  Y N 
Peer-to-Peer Recovery Support Services Yes No 
1. Peer Coaching or Mentoring Y N 
2. Housing Support Y N 
3. Alcohol- and Drug-Free Social Activities Y N 
4. Information and Referral Y N 
5. Other Peer-to-Peer Recovery Support 
Services (Specify) _________________  Y N 
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A. Record Management - Demographics [Asked only at intake/baseline.] 
1. What is your gender? 
 MALE 
 FEMALE 
 TRANSGENDER 
 OTHER (SPECIFY) ________________________________  
 REFUSED 
2. Are you Hispanic or Latino? 
 YES 
 NO 
 REFUSED 
[IF YES] What ethnic group do you consider yourself? Please answer yes or no for each of the following. 
You may say yes to more than one. 
 Yes No Refused 
Central American Y N REFUSED 
Cuban Y N REFUSED 
Dominican Y N REFUSED 
Mexican Y N REFUSED 
Puerto Rican Y N REFUSED 
South American Y N REFUSED 
Other Y N REFUSED [IF YES, SPECIFY BELOW.] 
(Specify)  _________________________________  
3. What is your race? Please answer yes or no for each of the following. You may say yes to more than one. 
  Yes No Refused 
Black or African American Y N REFUSED 
Asian Y N REFUSED 
Native Hawaiian or other Pacific Islander Y N REFUSED 
Alaska Native Y N REFUSED 
White Y N REFUSED 
American Indian Y N REFUSED 
4. What is your date of birth?* 
|____|____| / |____|____| / [*THE SYSTEM WILL ONLY SAVE MONTH AND YEAR. 
 Month Day TO MAINTAIN CONFIDENTIALITY, DAY IS NOT SAVED.] 
|____|____|____|____| 
 Year 
 REFUSED 
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MILITARY FAMILY AND DEPLOYMENT 
5. Have you ever served in the Armed Forces, in the Reserves, or in the National Guard? [IF SERVED] What 
area, the Armed Forces, Reserves, or National Guard did you serve? 
 NO 
 YES, IN THE ARMED FORCES 
 YES, IN THE RESERVES 
 YES, IN THE NATIONAL GUARD 
 REFUSED 
 DON’T KNOW 
[IF NO, REFUSED, OR DON’T KNOW, SKIP TO QUESTION A6.] 
5a. Are you currently on active duty in the Armed Forces, in the Reserves, or in the National Guard? 
[IF ACTIVE] What area, the Armed Forces, Reserves, or National Guard? 
 NO, SEPARATED OR RETIRED FROM THE ARMED FORCES, RESERVES, OR NATIONAL GUARD 
 YES, IN THE ARMED FORCES 
 YES, IN THE RESERVES 
 YES, IN THE NATIONAL GUARD 
 REFUSED 
 DON’T KNOW 
5b. Have you ever been deployed to a combat zone? [CHECK ALL THAT APPLY.] 
 NEVER DEPLOYED 
 IRAQ OR AFGHANISTAN (E.G., OEF/OIF/OND) 
 PERSIAN GULF (OPERATION DESERT SHIELD/DESERT STORM) 
 VIETNAM/SOUTHEAST ASIA 
 KOREA 
 WWII 
 DEPLOYED TO A COMBAT ZONE NOT LISTED ABOVE (E.G., BOSNIA/SOMALIA) 
 REFUSED 
 DON’T KNOW 
[SBIRT GRANTEES: FOR CLIENTS WHO SCREENED NEGATIVE, SKIP ITEMS A6, A6a THROUGH A6d.] 
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6. Is anyone in your family or someone close to you on active duty in the Armed Forces, in the Reserves, or in 
the National Guard or separated or retired from the Armed Forces, Reserves, or National Guard? 
 NO 
 YES, ONLY ONE 
 YES, MORE THAN ONE 
 REFUSED 
 DON’T KNOW 
[IF NO, REFUSED, OR DON’T KNOW, SKIP TO SECTION B.] 
[IF YES, ANSWER FOR UP TO 6 PEOPLE] What is the relationship of that person (Service Member) to you? [WRITE 
RELATIONSHIP IN COLUMN HEADING] 
1 = Mother  2 = Father 
3 = Brother  4 = Sister 
5 = Spouse  6 = Partner 
7 = Child  8 = Other (Specify)___________________ 
Has the Service Member 
experienced any of the 
following? [CHECK ANSWER 
IN APPROPRIATE COLUMN 
FOR ALL THAT APPLY] 
_________ 
(Relationship) 
1. 
_________ 
(Relationship)
2. 
_________ 
(Relationship)
3. 
_________ 
(Relationship) 
4. 
_________ 
(Relationship)
5. 
_________ 
(Relationship)
6. 
6a.  Deployed in support of 
combat operations 
(e.g., Iraq or 
Afghanistan)? 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
6b. Was physically injured 
during combat 
operations? 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
6c.  Developed combat 
stress symptoms/ 
difficulties adjusting 
following deployment, 
including PTSD, 
depression, or suicidal 
thoughts? 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
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6d. Died or was killed?    YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
  YES 
  NO 
  REFUSED 
  DON’T 
KNOW 
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B. Drug and Alcohol Use 
 Number 
 of Days REFUSED DON’T KNOW 
1. During the past 30 days, how many days have you used the 
following: 
a. Any alcohol [IF ZERO, SKIP TO ITEM B1c.] |____|____|   
b1. Alcohol to intoxication (5+ drinks in one sitting) |____|____|   
b2. Alcohol to intoxication (4 or fewer drinks in one sitting and felt 
high) |____|____|   
c. Illegal drugs [IF B1a OR B1c = 0, RF, DK, THEN SKIP TO 
ITEM B2.] |____|____|   
d. Both alcohol and drugs (on the same day) |____|____|   
Route of Administration Types: 
1. Oral    2. Nasal    3. Smoking   4. Non‐IV injection   5. IV 
*NOTE THE USUAL ROUTE. FOR MORE THAN ONE ROUTE, CHOOSE THE 
MOST SEVERE. THE ROUTES ARE LISTED FROM LEAST SEVERE (1) TO 
MOST SEVERE (5). 
2. During the past 30 days, how many days have you used any of 
the following: [IF THE VALUE IN ANY ITEM B2a THROUGH 
B2i > 0, THEN THE VALUE IN B1c MUST BE > 0.] 
 Number 
 of Days RF DK Route* RF DK 
a. Cocaine/Crack |____|____|   |____|   
b. Marijuana/Hashish (Pot, Joints, Blunts, Chronic, Weed, Mary 
Jane) |____|____|   |____|   
c. Opiates: 
1. Heroin (Smack, H, Junk, Skag) |____|____|   |____|   
2. Morphine |____|____|   |____|   
3. Dilaudid |____|____|   |____|   
4. Demerol |____|____|   |____|   
5. Percocet |____|____|   |____|   
6. Darvon |____|____|   |____|   
7. Codeine |____|____|   |____|   
8. Tylenol 2, 3, 4 |____|____|   |____|   
9. OxyContin/Oxycodone |____|____|   |____|  ‘ 
d. Non-prescription methadone |____|____|   |____|   
e. Hallucinogens/psychedelics, PCP (Angel Dust, Ozone, Wack, 
Rocket Fuel), MDMA (Ecstasy, XTC, X, Adam), LSD (Acid, 
Boomers, Yellow Sunshine), Mushrooms, or Mescaline |____|____|   |____|   
f. Methamphetamine or other amphetamines (Meth, Uppers, 
Speed, Ice, Chalk, Crystal, Glass, Fire, Crank) |____|____|   |____|   
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B. DRUG AND ALCOHOL USE (CONTINUED) 
Route of Administration Types: 
1. Oral    2. Nasal    3. Smoking   4. Non‐IV injection   5. IV 
*NOTE THE USUAL ROUTE. FOR MORE THAN ONE ROUTE, CHOOSE THE 
MOST SEVERE. THE ROUTES ARE LISTED FROM LEAST SEVERE (1) TO 
MOST SEVERE (5). 
2. During the past 30 days, how many days have you used any of 
the following: [IF THE VALUE IN ANY ITEM B2a THROUGH 
B2i > 0, THEN THE VALUE IN B1c MUST BE > 0.] 
 Number 
 of Days RF DK Route* RF DK 
g. 1. Benzodiazepines: Diazepam (Valium); Alprazolam (Xanax); 
Triazolam (Halcion); and Estasolam (Prosom and 
Rohypnol—also known as roofies, roche, and cope) |____|____|   |____|   
2. Barbiturates: Mephobarbital (Mebacut) and pentobarbital 
sodium (Nembutal) |____|____|   |____|   
3. Non-prescription GHB (known as Grievous Bodily Harm, 
Liquid Ecstasy, and Georgia Home Boy) |____|____|   |____|   
4. Ketamine (known as Special K or Vitamin K) |____|____|   |____|   
5. Other tranquilizers, downers, sedatives, or hypnotics |____|____|   |____|   
h. Inhalants (poppers, snappers, rush, whippets) |____|____|   |____|   
i. Other illegal drugs (Specify)  __________________________  |____|____|   |____|   
3. In the past 30 days, have you injected drugs? [IF ANY ROUTE OF ADMINISTRATION IN B2a THROUGH 
B2i = 4 or 5, THEN B3 MUST = YES.] 
 YES 
 NO 
 REFUSED 
 DON’T KNOW 
[IF NO, REFUSED, OR DON’T KNOW, SKIP TO SECTION C.] 
4. In the past 30 days, how often did you use a syringe/needle, cooker, cotton, or water that someone else used? 
 Always 
 More than half the time 
 Half the time 
 Less than half the time 
 Never 
 REFUSED 
 DON’T KNOW 
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C. Family and Living Conditions 
1. In the past 30 days, where have you been living most of the time? [DO NOT READ RESPONSE OPTIONS TO 
CLIENT.] 
 SHELTER (SAFE HAVENS, TRANSITIONAL LIVING CENTER [TLC], LOW-DEMAND FACILITIES, 
RECEPTION CENTERS, OTHER TEMPORARY DAY OR EVENING FACILITY) 
 STREET/OUTDOORS (SIDEWALK, DOORWAY, PARK, PUBLIC OR ABANDONED BUILDING) 
 INSTITUTION (HOSPITAL, NURSING HOME, JAIL/PRISON) 
 HOUSED: [IF HOUSED, CHECK APPROPRIATE SUBCATEGORY:] 
 OWN/RENT APARTMENT, ROOM, OR HOUSE 
 SOMEONE ELSE’S APARTMENT, ROOM, OR HOUSE 
 DORMITORY/COLLEGE RESIDENCE 
 HALFWAY HOUSE 
 RESIDENTIAL TREATMENT 
 OTHER HOUSED (SPECIFY) ___________________________________________________________  
 REFUSED 
 DON’T KNOW 
2. During the past 30 days, how stressful have things been for you because of your use of alcohol or other 
drugs? [IF B1a OR B1c > 0, THEN C2 CANNOT = “NOT APPLICABLE.”] 
 Not at all 
 Somewhat 
 Considerably 
 Extremely 
 NOT APPLICABLE [USE ONLY IF B1A AND B1C = 0.] 
 REFUSED 
 DON’T KNOW 
3. During the past 30 days, has your use of alcohol or other drugs caused you to reduce or give up important 
activities? [IF B1a OR B1c > 0, THEN C3 CANNOT = “NOT APPLICABLE.”] 
 Not at all 
 Somewhat 
 Considerably 
 Extremely 
 NOT APPLICABLE [USE ONLY IF B1A AND B1C = 0.] 
 REFUSED 
 DON’T KNOW 
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C. Family and Living Conditions (CONTINUED) 
4. During the past 30 days, has your use of alcohol or other drugs caused you to have emotional problems? 
[IF B1a OR B1c > 0, THEN C4 CANNOT = “NOT APPLICABLE.”] 
 Not at all 
 Somewhat 
 Considerably 
 Extremely 
 NOT APPLICABLE [USE ONLY IF B1a AND B1c = 0.] 
 REFUSED 
 DON’T KNOW 
5. [IF NOT MALE] Are you currently pregnant? 
 YES 
 NO 
 REFUSED 
 DON’T KNOW 
6. Do you have children? 
 YES 
 NO 
 REFUSED 
 DON’T KNOW 
[IF NO, REFUSED, OR DON’T KNOW, SKIP TO SECTION D.] 
a. How many children do you have? [IF C6 = YES, THEN THE VALUE IN C6a MUST BE > 0.] 
|____|____|  REFUSED  DON’T KNOW 
b. Are any of your children living with someone else due to a child protection court order? 
 YES 
 NO 
 REFUSED 
 DON’T KNOW 
[IF NO, REFUSED, OR DON’T KNOW, SKIP TO ITEM C6D.] 
c. [IF YES] How many of your children are living with someone else due to a child protection court 
order? [THE VALUE IN C6c CANNOT EXCEED THE VALUE IN C6a.] 
|____|____|  REFUSED  DON’T KNOW 
d. For how many of your children have you lost parental rights? [THE CLIENT’S PARENTAL 
RIGHTS WERE TERMINATED.] [THE VALUE IN ITEM C6d CANNOT EXCEED THE VALUE IN 
C6a.] 
|____|____|  REFUSED  DON’T KNOW 
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D. Education, Employment, and Income 
1. Are you currently enrolled in school or a job training program? [IF ENROLLED] Is that full time or part 
time? [IF CLIENT IS INCARCERATED, CODE D1 AS “NOT ENROLLED.”] 
 NOT ENROLLED 
 ENROLLED, FULL TIME 
 ENROLLED, PART TIME 
 OTHER (SPECIFY) ________________________________  
 REFUSED 
 DON’T KNOW 
2. What is the highest level of education you have finished, whether or not you received a degree? 
 NEVER ATTENDED 
 1ST GRADE 
 2ND GRADE 
 3RD GRADE 
 4TH GRADE 
 5TH GRADE 
 6TH GRADE 
 7TH GRADE 
 8TH GRADE 
 9TH GRADE 
 10TH GRADE 
 11TH GRADE 
 12TH GRADE/HIGH SCHOOL DIPLOMA/EQUIVALENT 
 COLLEGE OR UNIVERSITY/1ST YEAR COMPLETED 
 COLLEGE OR UNIVERSITY/2ND YEAR COMPLETED/ASSOCIATES DEGREE (AA, AS) 
 COLLEGE OR UNIVERSITY/3RD YEAR COMPLETED 
 BACHELOR’S DEGREE (BA, BS) OR HIGHER 
 VOC/TECH PROGRAM AFTER HIGH SCHOOL BUT NO VOC/TECH DIPLOMA 
 VOC/TECH DIPLOMA AFTER HIGH SCHOOL 
 REFUSED 
 DON’T KNOW 
3. Are you currently employed? [CLARIFY BY FOCUSING ON STATUS DURING MOST OF THE 
PREVIOUS WEEK, DETERMINING WHETHER CLIENT WORKED AT ALL OR HAD A REGULAR JOB 
BUT WAS OFF WORK.] [IF CLIENT IS “ENROLLED, FULL TIME” IN D1 AND INDICATES 
“EMPLOYED, FULL TIME” IN D3, ASK FOR CLARIFICATION. IF CLIENT IS INCARCERATED AND 
HAS NO WORK OUTSIDE OF JAIL, CODE D3 AS “UNEMPLOYED, NOT LOOKING FOR WORK.”] 
 EMPLOYED, FULL TIME (35+ HOURS PER WEEK, OR WOULD HAVE BEEN) 
 EMPLOYED, PART TIME 
 UNEMPLOYED, LOOKING FOR WORK 
 UNEMPLOYED, DISABLED 
 UNEMPLOYED, VOLUNTEER WORK 
 UNEMPLOYED, RETIRED 
 UNEMPLOYED, NOT LOOKING FOR WORK 
 OTHER (SPECIFY) ________________________________  
 REFUSED 
 DON’T KNOW 
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D. Education, Employment, and Income (CONTINUED) 
4. Approximately, how much money did YOU receive (pre-tax individual income) in the past 30 days from… 
[IF D3 DOES NOT = “EMPLOYED” AND THE VALUE IN D4a IS GREATER THAN ZERO, PROBE. IF 
D3 = “UNEMPLOYED, LOOKING FOR WORK” AND THE VALUE IN D4b = 0, PROBE. IF D3 = 
“UNEMPLOYED, RETIRED” AND THE VALUE IN D4c = 0, PROBE. IF D3 = “UNEMPLOYED, 
DISABLED” AND THE VALUE IN D4d = 0, PROBE.] 
 RF DK 
a. Wages $ |__|__|__| , |__|__|__|   
b. Public assistance $ |__|__|__| , |__|__|__|   
c. Retirement $ |__|__|__| , |__|__|__|   
d. Disability $ |__|__|__| , |__|__|__|   
e. Non-legal income $ |__|__|__| , |__|__|__|   
f. Family and/or friends $ |__|__|__| , |__|__|__|   
g. Other (Specify) $ |__|__|__| , |__|__|__|   
  __________________  
E. Crime and Criminal Justice Status 
1. In the past 30 days, how many times have you been arrested? 
|____|____| TIMES  REFUSED  DON’T KNOW 
[IF NO ARRESTS, SKIP TO ITEM E3.] 
2. In the past 30 days, how many times have you been arrested for drug-related offenses? [THE VALUE IN 
E2 CANNOT BE GREATER THAN THE VALUE IN E1.] 
|____|____| TIMES  REFUSED  DON’T KNOW 
3. In the past 30 days, how many nights have you spent in jail/prison? [IF THE VALUE IN E3 IS GREATER 
THAN 15, THEN C1 MUST = INSTITUTION (JAIL/PRISON). IF C1 = INSTITUTION (JAIL/PRISON), 
THEN THE VALUE IN E3 MUST BE GREATER THAN OR EQUAL TO 15.] 
|____|____| NIGHTS  REFUSED  DON’T KNOW 
4. In the past 30 days, how many times have you committed a crime? [CHECK NUMBER OF DAYS USED 
ILLEGAL DRUGS IN ITEM B1c ON PAGE 7. ANSWER HERE IN E4 SHOULD BE EQUAL TO OR 
GREATER THAN NUMBER IN B1c BECAUSE USING ILLEGAL DRUGS IS A CRIME.] 
|____|____|____| TIMES  REFUSED  DON’T KNOW 
5. Are you currently awaiting charges, trial, or sentencing? 
 YES 
 NO 
 REFUSED 
 DON’T KNOW 
6. Are you currently on parole or probation? 
 YES 
 NO 
 REFUSED 
 DON’T KNOW 
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F. Mental and Physical Health Problems and Treatment/Recovery 
1. How would you rate your overall health right now? 
 Excellent 
 Very good 
 Good 
 Fair 
 Poor 
 REFUSED 
 DON’T KNOW 
2. During the past 30 days, did you receive: 
a.  Inpatient Treatment for: 
YES 
[IF YES] 
Altogether  
for how many nights  NO  RF  DK 
i.  Physical complaint      ______  nights       
ii.  Mental or emotional difficulties      ______  nights       
iii.  Alcohol or substance abuse      ______  nights       
 
b.  Outpatient Treatment for: 
YES 
[IF YES] 
Altogether  
for how many times  NO  RF  DK 
i.  Physical complaint      _______ times       
ii.  Mental or emotional difficulties      _______ times       
iii.  Alcohol or substance abuse      _______ times       
 
c.  Emergency Room Treatment for: 
YES 
[IF YES] 
Altogether  
for how many times  NO  RF  DK 
i.  Physical complaint      _______ times       
ii.  Mental or emotional difficulties      _______ times       
iii.  Alcohol or substance abuse      _______ times       
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F. MENTAL AND PHYSICAL HEALTH PROBLEMS AND TREATMENT/RECOVERY 
(CONTINUED) 
3. During the past 30 days, did you engage in sexual activity? 
 Yes 
 No → [SKIP TO F4.] 
 NOT PERMITTED TO ASK → [SKIP TO F4.] 
 REFUSED → [SKIP TO F4.] 
 DON’T KNOW → [SKIP TO F4.] 
[IF YES] Altogether, how many: 
 Contacts RF DK 
a. Sexual contacts (vaginal, oral, or anal) did you have? |____|____|____|   
b. Unprotected sexual contacts did you have? [THE VALUE 
IN F3b SHOULD NOT BE GREATER THAN THE 
VALUE IN F3a.] [IF ZERO, SKIP TO F4.] |____|____|____|   
c. Unprotected sexual contacts were with an individual who is 
or was: [NONE OF THE VALUES IN F3c1 THROUGH 
F3c3 CAN BE GREATER THAN THE VALUE IN F3b.] 
1. HIV positive or has AIDS |____|____|____|   
2. An injection drug user |____|____|____|   
3. High on some substance |____|____|____|   
4. Have you ever been tested for HIV? 
 Yes .......................... [GO TO F4a.] 
 No ........................... [SKIP TO F5.] 
 REFUSED .............. [SKIP TO F5.] 
 DON’T KNOW ...... [SKIP TO F5.] 
4a. Do you know the results of your HIV testing? 
 Yes 
 No  
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F. MENTAL AND PHYSICAL HEALTH PROBLEMS AND TREATMENT/RECOVERY 
(CONTINUED) 
5. In the past 30 days, not due to your use of alcohol or drugs, how many days have you: 
 Days RF DK 
a. Experienced serious depression |____|____|   
b. Experienced serious anxiety or tension |____|____|   
c. Experienced hallucinations |____|____|   
d. Experienced trouble understanding, concentrating, or 
remembering |____|____|   
e. Experienced trouble controlling violent behavior |____|____|   
f. Attempted suicide |____|____|   
g. Been prescribed medication for psychological/emotional 
problem |____|____|   
[IF CLIENT REPORTS ZERO DAYS, RF, OR DK TO ALL ITEMS IN QUESTION 5, SKIP TO ITEM F7.] 
6. How much have you been bothered by these psychological or emotional problems in the past 30 days? 
 Not at all 
 Slightly 
 Moderately 
 Considerably 
 Extremely 
 REFUSED 
 DON’T KNOW 
VIOLENCE AND TRAUMA 
7. Have you ever experienced violence or trauma in any setting (including community or school violence; 
domestic violence; physical, psychological, or sexual maltreatment/assault within or outside of the family; 
natural disaster; terrorism; neglect; or traumatic grief?) 
 YES 
 NO [SKIP TO ITEM F8.] 
 REFUSED 
 DON’T KNOW 
[IF NO, REFUSED, OR DON’T KNOW, SKIP TO ITEM F8.] 
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F. MENTAL AND PHYSICAL HEALTH PROBLEMS AND TREATMENT/RECOVERY 
(CONTINUED) 
Did any of these experiences feel so frightening, horrible, or upsetting that, in the past and/or the present, 
you: 
7a. Have had nightmares about it or thought about it when you did not want to? 
 YES 
 NO 
 REFUSED 
 DON’T KNOW 
7b. Tried hard not to think about it or went out of your way to avoid situations that remind you of it? 
 YES 
 NO 
 REFUSED 
 DON’T KNOW 
7c. Were constantly on guard, watchful, or easily startled? 
 YES 
 NO 
 REFUSED 
 DON’T KNOW 
7d. Felt numb and detached from others, activities, or your surroundings? 
 YES 
 NO 
 REFUSED 
 DON’T KNOW 
8. In the past 30 days, how often have you been hit, kicked, slapped, or otherwise physically hurt? 
 Never 
 A few times 
 More than a few times 
 REFUSED 
 DON’T KNOW 
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G. Social Connectedness 
1. In the past 30 days, did you attend any voluntary self-help groups for recovery that were not affiliated with 
a religious or faith-based organization? In other words, did you participate in a non-professional, peer-
operated organization that is devoted to helping individuals who have addiction-related problems such as: 
Alcoholics Anonymous, Narcotics Anonymous, Oxford House, Secular Organization for Sobriety, or 
Women for Sobriety, etc.? 
 YES [IF YES] SPECIFY HOW MANY TIMES |____|____|  REFUSED  DON’T KNOW 
 NO 
 REFUSED 
 DON’T KNOW 
2. In the past 30 days, did you attend any religious/faith-affiliated recovery self-help groups? 
 YES [IF YES] SPECIFY HOW MANY TIMES |____|____|  REFUSED  DON’T KNOW 
 NO 
 REFUSED 
 DON’T KNOW 
3. In the past 30 days, did you attend meetings of organizations that support recovery other than the 
organizations described above? 
 YES [IF YES] SPECIFY HOW MANY TIMES |____|____|  REFUSED  DON’T KNOW 
 NO 
 REFUSED 
 DON’T KNOW 
4. In the past 30 days, did you have interaction with family and/or friends that are supportive of your 
recovery? 
 YES 
 NO 
 REFUSED 
 DON’T KNOW 
5. To whom do you turn when you are having trouble? [SELECT ONLY ONE.] 
 NO ONE 
 CLERGY MEMBER 
 FAMILY MEMBER 
 FRIENDS 
 REFUSED 
 DON’T KNOW 
 OTHER (SPECIFY) ________________________________  
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I. Follow-Up Status 
[REPORTED BY PROGRAM STAFF ABOUT CLIENT ONLY AT FOLLOW-UP.] 
1. What is the follow-up status of the client? [THIS IS A REQUIRED FIELD: NA, REFUSED, DON’T KNOW, 
AND MISSING WILL NOT BE ACCEPTED.] 
 01 = Deceased at time of due date 
 11 = Completed interview within specified window 
 12 = Completed interview outside specified window 
 21 = Located, but refused, unspecified 
 22 = Located, but unable to gain institutional access 
 23 = Located, but otherwise unable to gain access 
 24 = Located, but withdrawn from project 
 31 = Unable to locate, moved 
 32 = Unable to locate, other (Specify) ________________________ 
2. Is the client still receiving services from your program? 
 Yes 
 No 
[IF THIS IS A FOLLOW-UP INTERVIEW, STOP NOW; THE INTERVIEW IS COMPLETE.] 
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J. Discharge Status 
[REPORTED BY PROGRAM STAFF ABOUT CLIENT ONLY AT DISCHARGE.] 
1. On what date was the client discharged? 
|____|____| / |____|____| / |____|____|____|____| 
 MONTH DAY YEAR 
2. What is the client’s discharge status? 
 01 = Completion/Graduate 
 02 = Termination 
If the client was terminated, what was the reason for termination? [SELECT ONE RESPONSE.] 
 01 = Left on own against staff advice with satisfactory progress 
 02 = Left on own against staff advice without satisfactory progress 
 03 = Involuntarily discharged due to nonparticipation 
 04 = Involuntarily discharged due to violation of rules 
 05 = Referred to another program or other services with satisfactory progress 
 06 = Referred to another program or other services with unsatisfactory progress 
 07 = Incarcerated due to offense committed while in treatment/recovery with satisfactory progress 
 08 = Incarcerated due to offense committed while in treatment/recovery with unsatisfactory progress 
 09 = Incarcerated due to old warrant or charged from before entering treatment/recovery with satisfactory 
progress 
 10 = Incarcerated due to old warrant or charged from before entering treatment/recovery with 
unsatisfactory progress 
 11 = Transferred to another facility for health reasons 
 12 = Death 
 13 = Other (Specify) __________________________________  
3. Did the program test this client for HIV? 
 Yes [SKIP TO SECTION K.] 
 No [GO TO J4.] 
4. [IF NO] Did the program refer this client for testing? 
 Yes 
 No 
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K. Services Received 
[REPORTED BY PROGRAM STAFF ABOUT CLIENT ONLY AT DISCHARGE.] 
 Identify the number of DAYS of services provided to the client during the client’s course of 
treatment/recovery. [ENTER ZERO IF NO SERVICES PROVIDED. YOU SHOULD HAVE AT LEAST ONE DAY 
FOR MODALITY.] 
Modality Days 
1. Case Management |___|___|___| 
2. Day Treatment |___|___|___| 
3. Inpatient/Hospital (Other Than Detox) |___|___|___| 
4. Outpatient |___|___|___| 
5. Outreach |___|___|___| 
6. Intensive Outpatient |___|___|___| 
7. Methadone |___|___|___| 
8. Residential/Rehabilitation |___|___|___| 
9. Detoxification (Select Only One): 
A. Hospital Inpatient |___|___|___| 
B. Free Standing Residential |___|___|___| 
C. Ambulatory Detoxification |___|___|___| 
10. After Care |___|___|___| 
11. Recovery Support |___|___|___| 
12. Other (Specify) _________________  |___|___|___| 
Identify the number of SESSIONS provided to the client during the client’s course of treatment/
recovery. [ENTER ZERO IF NO SERVICES PROVIDED.] 
Treatment Services Sessions 
[SBIRT GRANTS: YOU MUST HAVE AT LEAST ONE SESSION FOR ONE OF THE TREATMENT SERVICES 
NUMBERED 1 THROUGH 4.] 
1. Screening |___|___|___| 
2. Brief Intervention |___|___|___| 
3. Brief Treatment |___|___|___| 
4. Referral to Treatment |___|___|___| 
5. Assessment |___|___|___| 
6. Treatment/Recovery Planning |___|___|___| 
7. Individual Counseling |___|___|___| 
8. Group Counseling |___|___|___| 
9. Family/Marriage Counseling |___|___|___| 
10. Co-Occurring Treatment/Recovery Services|___|___|___| 
11. Pharmacological Interventions |___|___|___| 
12. HIV/AIDS Counseling |___|___|___| 
13. Other Clinical Services  
(Specify) ______________________  |___|___|___| 
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Case Management Services Sessions 
1. Family Services (Including Marriage Education, Parenting, Child Development 
Services) |___|___|___| 
2. Child Care |___|___|___| 
3. Employment Service 
A. Pre-Employment |___|___|___| 
B. Employment Coaching |___|___|___| 
4. Individual Services Coordination |___|___|___| 
5. Transportation |___|___|___| 
6. HIV/AIDS Service |___|___|___| 
7. Supportive Transitional Drug-Free Housing Services |___|___|___| 
8. Other Case Management Services (Specify)  |___|___|___| 
Medical Services Sessions 
1. Medical Care |___|___|___| 
2. Alcohol/Drug Testing |___|___|___| 
3. HIV/ AIDS Medical Support & Testing|___|___|___| 
4. Other Medical Services  
(Specify) ______________________  |___|___|___| 
After Care Services Sessions 
1. Continuing Care |___|___|___| 
2. Relapse Prevention |___|___|___| 
3. Recovery Coaching |___|___|___| 
4. Self-Help and Support Groups |___|___|___| 
5. Spiritual Support |___|___|___| 
6. Other After Care Services  
(Specify) ______________________  |___|___|___| 
Education Services Sessions 
1. Substance Abuse Education |___|___|___| 
2. HIV/AIDS Education |___|___|___| 
3. Other Education Services 
(Specify) ______________________  |___|___|___| 
Peer-to-Peer Recovery Support Services Sessions 
1. Peer Coaching or Mentoring |___|___|___| 
2. Housing Support |___|___|___| 
3. Alcohol- and Drug-Free Social Activities|___|___|___| 
4. Information and Referral |___|___|___| 
5. Other Peer-to-Peer Recovery Support Services (Specify)  |___|___|___| 
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